https://curecurrent.com/trials/real-time-assessment-of-breast-cancer-surgical-specimen-margins-with-nonlinear-microscopy-25001https://curecurrent.com/trials/watd-and-cancer-related-fatigue-a-study-for-patients-undergoing-anti-cancer-treatment-25002https://curecurrent.com/trials/energy-balance-interventions-in-increasing-physical-activity-in-breast-cancer-gene-positive-patients-lynch-syndrome-posi-25003https://curecurrent.com/trials/investigating-the-effects-of-atezolizumab-in-people-whose-tumour-dna-or-rna-indicates-possible-sensitivity-25004https://curecurrent.com/trials/efficacy-and-safety-study-of-halneuron-in-the-treatment-of-chemotherapy-induced-neuropathic-pain-25005https://curecurrent.com/trials/pbi-for-low-risk-breast-cancer-25006https://curecurrent.com/trials/neoadjuvant-inbrx-106-in-combination-with-pembrolizumab-for-stage-ii-iii-tnbc-patients-25007https://curecurrent.com/trials/cfi-400945-in-patients-with-advanced-metastatic-breast-cancer-25008https://curecurrent.com/trials/precision-supplemental-imaging-in-women-with-dense-breasts-25009https://curecurrent.com/trials/the-role-of-bisphosphonate-and-simvastatin-combination-on-therapeutic-response-in-breast-cancer-with-bone-metastasis-via-25010https://curecurrent.com/trials/patient-experiences-after-risk-reducing-mastectomy-among-women-carrying-brca1-2-pathogenic-variants-without-a-diagnosis-25011https://curecurrent.com/trials/phase-ii-neoadjuvant-pyrotinib-combined-with-neoadjuvant-chemotherapy-in-her2-low-expressing-and-hr-positive-early-or-lo-25012https://curecurrent.com/trials/magseed-pro-r-sentimag-r-gen3-25013https://curecurrent.com/trials/cardio-oncology-rehabilitation-in-breast-cancer-patients-undergoing-chemotherapy-25014https://curecurrent.com/trials/contribution-of-oncogenetics-in-breast-cancer-in-reunion-epidemiology-of-breast-cancer-in-reunion-study-of-the-reunion-m-25015https://curecurrent.com/trials/apatinib-with-cdk4-6-inhibitor-and-endocrine-therapy-in-hr-her2-advanced-breast-cancer-25016https://curecurrent.com/trials/combined-upper-extremity-resistance-and-aerobic-exercise-training-in-patients-with-breast-cancer-25017https://curecurrent.com/trials/endogenous-mechanisms-of-inactivation-of-the-endothelium-tumor-25018https://curecurrent.com/trials/quality-of-recovery-after-primary-breast-cancer-surgery-comparing-thoracic-paravertebral-block-and-intravenous-lidocaine-25019https://curecurrent.com/trials/feasibility-study-ignite-tx-identifying-individuals-for-genetic-testing-treatment-intervention-25020https://curecurrent.com/trials/evaluating-mechanical-properties-of-post-mastectomy-skin-flaps-to-estimate-reconstruction-risks-the-empower-study-25021https://curecurrent.com/trials/a-study-of-breast-cancer-risk-factors-and-outcomes-of-people-in-florida-25022https://curecurrent.com/trials/mediterranean-diet-and-inequality-in-early-breast-cancer-25023https://curecurrent.com/trials/analysis-of-multimodal-psychosomatic-comorbidity-burden-in-breast-cancer-and-benefit-evaluation-of-acupuncture-collabora-25024https://curecurrent.com/trials/tc99m-sestamibi-molecular-breast-imaging-25025https://curecurrent.com/trials/breast-margin-study-routine-cavity-shave-margins-vs-selective-margins-using-savi-scout-25026https://curecurrent.com/trials/neoadjuvant-culmerciclib-combined-with-endocrine-therapy-for-hormone-receptor-positive-human-epidermal-growth-factor-rec-25027https://curecurrent.com/trials/long-term-safety-and-efficacy-of-gbg-study-participants-25028https://curecurrent.com/trials/standard-verbal-counseling-with-or-without-a-pictorial-educational-tool-for-the-reduction-of-psychological-morbidity-in-25029https://curecurrent.com/trials/feasibility-study-to-evaluate-the-use-of-patient-reported-complications-after-digital-consent-25030https://curecurrent.com/trials/a-first-in-human-dose-escalation-of-dendritic-cell-vaccine-dcv-25031https://curecurrent.com/trials/adoptive-t-cell-therapy-following-her2-pulsed-dendritic-cell-vaccine-pepinemab-trastuzumab-in-patients-w-metastatic-her2-25032https://curecurrent.com/trials/evaluation-of-the-impact-of-pre-habilitation-using-physiotherapy-and-mechanical-stimulation-on-shoulder-pain-and-mobilit-25033https://curecurrent.com/trials/stibium-metallicum-praeparatum-d6-versus-placebo-in-the-reduction-of-paclitaxel-induced-peripheral-neurotoxicity-25034https://curecurrent.com/trials/sl-28-for-advanced-solid-tumours-25035https://curecurrent.com/trials/evaluation-and-outcomes-of-savi-scout-md-for-localized-breast-surgery-25036https://curecurrent.com/trials/a-nurse-led-coping-and-supportive-intervention-for-patients-with-triple-negative-breast-cancer-25037https://curecurrent.com/trials/assessment-of-adherence-to-remotely-monitored-physical-activity-tracked-on-a-smartwatch-and-its-impact-on-reducing-fatig-25038https://curecurrent.com/trials/abbreviated-mbct-for-depression-in-older-black-or-african-american-breast-cancer-survivors-25039https://curecurrent.com/trials/muse-s-headband-system-for-improving-anxiety-and-insomnia-among-breast-cancer-survivors-25040https://curecurrent.com/trials/cognition-genomics-guided-precision-oncology-in-early-high-risk-breast-cancer-25041https://curecurrent.com/trials/68ga-bed003-pet-imaging-of-fibroblast-activation-protein-in-selected-oncology-indications-25042https://curecurrent.com/trials/utility-of-a-mobile-application-for-young-women-with-breast-cancer-25043https://curecurrent.com/trials/a-study-of-elacestrant-versus-standard-endocrine-therapy-in-women-and-men-with-er-her2-early-breast-cancer-with-high-ris-25044https://curecurrent.com/trials/everyday-exposures-how-chemicals-and-weight-impact-breast-cancer-risk-25045https://curecurrent.com/trials/a-study-of-iov-5001-in-adults-with-advanced-solid-tumors-25046https://curecurrent.com/trials/phase-1b-study-of-op-1250-palazestrant-in-combination-with-ribociclib-alpelisib-everolimus-or-atirmociclib-in-er-her2-br-25047https://curecurrent.com/trials/response-adapted-omission-of-nodal-boost-in-n3-breast-cancer-after-neoadjuvant-therapy-25048https://curecurrent.com/trials/axillary-surgery-after-neoadjuvant-treatment-25049https://curecurrent.com/trials/methods-for-localization-of-different-types-of-breast-lesions-25050https://curecurrent.com/trials/combination-of-mitomycin-and-carboplatin-in-neoadjuvant-therapy-in-brca-associated-triple-negative-locally-advanced-brea-25051https://curecurrent.com/trials/prehabilitation-intervention-to-modify-eating-for-breast-cancer-patients-prime-25052https://curecurrent.com/trials/timing-of-ctdna-testing-in-advanced-breast-cancer-25053https://curecurrent.com/trials/to-assess-the-correlation-of-high-resolution-specimen-pet-ct-imaging-using-the-xeos-aura-10-pet-ct-with-the-histopatholo-25054https://curecurrent.com/trials/prehabilitation-for-improving-outcomes-in-breast-cancer-patients-undergoing-neoadjuvant-systemic-treatment-and-surgery-25055https://curecurrent.com/trials/assessment-of-current-biomarker-testing-practices-for-common-solid-cancers-in-precision-oncology-in-the-community-settin-25056https://curecurrent.com/trials/study-of-screening-brain-mris-in-stage-iv-breast-cancer-25057https://curecurrent.com/trials/cem-to-reduce-biopsy-rates-for-less-than-highly-suspicious-breast-abnormalities-a-prospective-study-25058https://curecurrent.com/trials/covid-19-related-financial-hardship-and-distress-in-women-who-decline-tmist-ea1151-participation-25059https://curecurrent.com/trials/understanding-and-addressing-rejection-of-personalized-breast-cancer-risk-information-administrative-supplement-study-25060https://curecurrent.com/trials/study-to-investigate-efficacy-of-a-novel-probiotic-on-the-bacteriome-and-mycobiome-of-breast-cancer-25061https://curecurrent.com/trials/entinostat-nivolumab-and-ipilimumab-in-treating-patients-with-solid-tumors-that-are-metastatic-or-cannot-be-removed-by-s-25062https://curecurrent.com/trials/a-tissue-collection-study-in-patients-who-respond-to-immune-checkpoint-inhibitors-to-identify-targets-of-tumor-reactive-25063https://curecurrent.com/trials/study-of-art6043-in-advanced-metastatic-solid-tumors-patients-polka-25064https://curecurrent.com/trials/digital-education-for-breast-cancer-screening-beliefs-and-prevention-behaviors-25065https://curecurrent.com/trials/a-study-comparing-bl-m07d1-with-ds-8201-in-patients-with-hr-positive-her2-low-expressing-recurrent-metastatic-breast-can-25066https://curecurrent.com/trials/korea-post-marketing-surveillance-pms-study-of-talzenna-25067https://curecurrent.com/trials/safety-pk-and-efficacy-of-onc-392-in-monotherapy-and-in-combination-of-anti-pd-1-in-advanced-solid-tumors-and-nsclc-25068https://curecurrent.com/trials/tens-compression-and-cryotherapy-for-paclitaxel-induced-peripheral-neuropathy-in-women-with-breast-cancer-25069https://curecurrent.com/trials/dance-based-exercise-for-cancer-related-fatigue-in-breast-cancer-patients-25070https://curecurrent.com/trials/hypnosedation-in-relaxing-patients-undergoing-breast-cancer-surgery-25071https://curecurrent.com/trials/a-study-evaluating-adherence-tolerability-and-patient-reported-outcomes-of-giredestrant-in-participants-with-er-her2-ear-25072https://curecurrent.com/trials/integrating-biological-clinical-and-behavioral-factors-to-improve-breast-cancer-outcomes-carolina-breast-cancer-study-25073https://curecurrent.com/trials/we-care-community-health-forums-to-increase-breast-cancer-screening-and-clinical-trial-participation-for-rural-and-low-i-25074https://curecurrent.com/trials/audit-of-targeted-sentinel-node-biopsy-tsnb-in-patients-with-limited-nodal-disease-undergoing-primary-surgery-25075https://curecurrent.com/trials/patient-specific-decision-aid-system-for-shared-decision-making-about-breast-reconstruction-25076https://curecurrent.com/trials/a-study-of-pembrolizumab-and-ablation-cryoablation-or-histotripsy-in-people-with-breast-cancer-25077https://curecurrent.com/trials/web-based-exercise-for-neuropathy-and-quality-of-life-in-breast-cancer-25078https://curecurrent.com/trials/phase-ii-study-of-shr-a1811-for-ultra-low-her2-advanced-breast-cancer-25079https://curecurrent.com/trials/real-world-study-of-trastuzumab-deruxtecan-in-patients-with-unresectable-or-metastatic-her2-low-breast-cancer-25080https://curecurrent.com/trials/to-identify-primary-resistance-to-cdk4-6-inhibitors-in-breast-cancer-25081https://curecurrent.com/trials/a-randomized-trial-of-five-fraction-partial-breast-irradiation-rapid2-25082https://curecurrent.com/trials/radiation-therapy-before-surgery-in-treating-patients-with-hormone-receptor-positive-her2-negative-breast-cancer-25083https://curecurrent.com/trials/oracle-observation-of-residual-cancer-with-liquid-biopsy-evaluation-25084https://curecurrent.com/trials/hypofractionated-partial-breast-irradiation-in-treating-patients-with-early-stage-breast-cancer-25085https://curecurrent.com/trials/bgb-21447-bcl-2-inhibitor-combinations-for-adults-with-hormone-receptor-positive-hr-human-epidermal-growth-factor-recept-25086https://curecurrent.com/trials/olaparib-with-cediranib-or-azd6738-for-the-treatment-of-advanced-or-metastatic-germline-brca-mutated-breast-cancer-25087https://curecurrent.com/trials/paravertebral-block-and-reduction-in-opioid-consumption-after-mastectomy-25088https://curecurrent.com/trials/a-study-to-evaluate-efficacy-and-safety-of-giredestrant-compared-with-fulvestrant-plus-a-cdk4-6-inhibitor-in-participant-25089https://curecurrent.com/trials/using-fdg-pet-ct-to-assess-response-of-bone-dominant-metastatic-breast-cancer-feature-study-25090https://curecurrent.com/trials/a-study-to-learn-about-the-study-medicine-called-pf-07220060-in-combination-with-pf-07104091-in-participants-with-breast-25091https://curecurrent.com/trials/68ga-ga-dota-5g-as-a-diagnostic-imaging-agent-for-metastatic-advanced-invasive-lobular-breast-cancer-lbc-25092https://curecurrent.com/trials/testing-longer-duration-radiation-therapy-versus-the-usual-radiation-therapy-in-patients-with-cancer-that-has-spread-to-25093https://curecurrent.com/trials/muscle-oxygenation-and-function-in-breast-cancer-survivors-25094https://curecurrent.com/trials/tier-palliative-care-for-patients-with-advanced-heart-failure-or-cancer-25095https://curecurrent.com/trials/risk-stratified-management-of-inavolisib-induced-hyperglycemia-and-patient-adherence-25096https://curecurrent.com/trials/testing-the-role-of-fdg-pet-ct-to-predict-response-to-therapy-prior-to-surgery-for-her2-positive-breast-cancer-the-direc-25097https://curecurrent.com/trials/study-of-olaparib-plus-pembrolizumab-versus-chemotherapy-plus-pembrolizumab-after-induction-with-first-line-chemotherapy-25098https://curecurrent.com/trials/compassher2-pcr-decreasing-chemotherapy-for-breast-cancer-patients-after-pre-surgery-chemo-and-targeted-therapy-25099https://curecurrent.com/trials/comparison-of-fulvestrant-faslodex-250-mg-and-500-mg-in-postmenopausal-women-with-oestrogen-receptor-positive-advanced-b-25100https://curecurrent.com/trials/first-in-human-study-of-tub-030-in-patients-with-advanced-solid-tumors-25101https://curecurrent.com/trials/pharmacopuncture-for-aromatase-inhibitor-induced-arthralgia-aia-25102https://curecurrent.com/trials/a-phase-i-iia-study-of-azd8205-given-alone-or-combined-in-participants-with-advanced-metastatic-solid-malignancies-25103https://curecurrent.com/trials/neoadjuvant-endocrine-therapy-the-pi3k-inhibitor-inavolisib-in-her2-hr-pik3ca-mutant-early-breast-cancer-25104https://curecurrent.com/trials/providence-prospective-non-interventional-study-nis-to-examine-patient-reported-outcomes-and-real-world-clinical-data-in-25105https://curecurrent.com/trials/minimally-interventional-study-on-prevalence-of-emerging-esr1-mutations-in-liquid-biopsy-in-three-cohorts-of-patients-wi-25106https://curecurrent.com/trials/study-on-the-efficacy-and-safety-of-body-tuning-voice-tuning-mind-tuning-three-dimensional-integrated-art-therapy-in-reg-25107https://curecurrent.com/trials/a-study-evaluating-the-efficacy-and-safety-of-giredestrant-compared-with-physician-s-choice-of-endocrine-monotherapy-in-25108https://curecurrent.com/trials/sibyl-observation-of-therapy-response-with-liquid-biopsy-evaluation-25109https://curecurrent.com/trials/active-surveillance-in-older-women-with-er-breast-cancer-25110https://curecurrent.com/trials/evaluation-of-novel-iron-based-lymphatic-mapping-agent-magtrace-for-delayed-sentinel-lymph-node-biopsy-slnb-in-ductal-ca-25111https://curecurrent.com/trials/a-preregistered-multi-cohort-evaluation-of-the-fathom-ai-system-for-molecular-testing-prioritization-to-support-clinical-25112https://curecurrent.com/trials/a-study-of-multiparametric-mri-and-phlip-icg-in-breast-cancer-imaging-during-surgery-25113https://curecurrent.com/trials/promoting-active-living-among-people-with-advanced-cancer-25114https://curecurrent.com/trials/phase-4-study-to-assess-the-safety-of-trastuzumab-deruxtecan-in-indian-patients-25115https://curecurrent.com/trials/impact-of-proximal-motor-control-exercise-on-scapular-muscles-activation-pattern-in-breast-cancer-survivors-following-ma-25116https://curecurrent.com/trials/a-study-evaluating-the-efficacy-and-safety-of-inavolisib-palbociclib-fulvestrant-vs-placebo-palbociclib-fulvestrant-in-p-25117https://curecurrent.com/trials/low-dose-tamoxifen-and-lifestyle-changes-for-breast-cancer-prevention-25118https://curecurrent.com/trials/developing-a-virtual-stress-management-intervention-for-spousal-partnered-caregivers-of-solid-tumor-cancer-patients-25119https://curecurrent.com/trials/guaran-supplementation-for-cancer-related-fatigue-25120https://curecurrent.com/trials/continue-the-same-systemic-therapy-after-local-ablative-therapy-for-oligo-progression-in-metastatic-breast-cancer-the-co-25121https://curecurrent.com/trials/a-study-to-investigate-safety-and-tolerability-of-transcon-il-2-alone-or-in-combination-with-pembrolizumab-and-or-transc-25122https://curecurrent.com/trials/international-prospective-registry-on-pre-pectoral-breast-reconstruction-25123https://curecurrent.com/trials/ovarian-cancer-liquid-biopsy-for-early-assessment-detection-in-individuals-with-brca1-2-pathogenic-variants-25124https://curecurrent.com/trials/can-deep-fascial-thickness-predict-treatment-response-in-patients-with-postmastectomy-lymphedema-an-ultrasonographic-app-25125https://curecurrent.com/trials/hope-genomics-intervention-for-the-improvement-of-cancer-patient-knowledge-of-genomics-25126https://curecurrent.com/trials/palbociclib-after-cdk-and-endocrine-therapy-pace-25127https://curecurrent.com/trials/ttx-080-hla-g-antagonist-in-subjects-with-advanced-cancers-25128https://curecurrent.com/trials/financial-toxicity-quality-of-life-and-psychological-resources-in-breast-cancer-survivors-a-longitudinal-study-25129https://curecurrent.com/trials/a-phase-i-ii-dose-finding-and-optimization-study-of-177lu-lu-neob-in-combination-with-capecitabine-in-patients-with-grpr-25130https://curecurrent.com/trials/mini-flap-baba-bilateral-axillo-breast-approach-robotic-thyroidectomy-is-safe-25131https://curecurrent.com/trials/177lu-lu-neob-in-combination-with-ribociclib-and-fulvestrant-in-participants-with-er-her2-and-grpr-advanced-breast-cance-25132https://curecurrent.com/trials/signature-development-and-validation-protocol-for-an-epigenetic-assay-in-diagnosing-breast-cancer-25133https://curecurrent.com/trials/study-of-patritumab-deruxtecan-plus-pembrolizumab-with-other-anticancer-agents-in-participants-with-high-risk-early-stag-25134https://curecurrent.com/trials/a-prospective-study-to-develop-and-clinically-validate-an-in-vitro-diagnostic-medical-device-that-uses-blood-to-classify-25135https://curecurrent.com/trials/phase-1-study-of-a-self-amplifying-rna-vaccine-iti-5000-in-stage-2-3-triple-negative-breast-cancer-25136https://curecurrent.com/trials/a-phase-2-bridging-study-of-elacestrant-monotherapy-in-advanced-or-metastatic-breast-cancer-25137https://curecurrent.com/trials/a-study-of-tobemstomig-nab-paclitaxel-compared-with-pembrolizumab-nab-paclitaxel-in-participants-with-previously-untreat-25138https://curecurrent.com/trials/a-study-of-al58805-in-advanced-metastatic-gyn-sts-or-breast-cancers-25139https://curecurrent.com/trials/a-study-of-si-b036-in-patients-with-locally-advanced-or-metastatic-breast-cancer-and-other-solid-tumors-25140https://curecurrent.com/trials/open-label-study-to-evaluate-bl-m07d1-in-her2-expressing-malignant-solid-tumors-25141https://curecurrent.com/trials/comparing-decision-on-aesthetics-after-breast-cancer-locoregional-treatment-25142https://curecurrent.com/trials/a-study-of-tucatinib-mk-7119-in-combination-with-trastuzumab-and-capecitabine-in-participants-with-previously-treated-lo-25143https://curecurrent.com/trials/impact-of-exercise-on-quality-of-life-of-ebc-patients-on-treatment-with-adjuvant-ai-with-or-without-cdk4-6-inhibitors-25144https://curecurrent.com/trials/a-clinical-trial-of-tqb2102-for-injection-in-the-treatment-of-her2-low-expressing-recurrent-metastatic-breast-cancer-25145https://curecurrent.com/trials/prism-trial-partial-breast-versus-whole-breast-radiation-in-early-breast-cancer-25146https://curecurrent.com/trials/study-of-radiotherapy-combined-with-cisplatin-carboplatin-adebrelimab-and-bevacizumab-in-the-treatment-of-tnbc-bm-25147https://curecurrent.com/trials/her2-pet-predicting-t-dxd-efficacy-and-her2-heterogeneity-25148https://curecurrent.com/trials/cyclophosphamide-and-veliparib-in-treating-patients-with-locally-advanced-or-metastatic-breast-cancer-25149https://curecurrent.com/trials/talave-induction-talazoparib-followed-by-combination-of-talazoparib-and-avelumab-in-advanced-breast-cancer-25150https://curecurrent.com/trials/study-assessing-the-efficacy-and-safety-of-alpelisib-nab-paclitaxel-in-subjects-with-advanced-tnbc-who-carry-either-a-pi-25151https://curecurrent.com/trials/a-study-evaluating-the-efficacy-and-safety-of-multiple-treatment-combinations-in-patients-with-metastatic-or-locally-adv-25152https://curecurrent.com/trials/implementing-patients-competence-in-oral-ebc-therapy-persistence-25153https://curecurrent.com/trials/eit-evaluation-of-pulmonary-ventilation-with-different-ropivacaine-concentrations-in-intercostal-nerve-blockade-25154https://curecurrent.com/trials/a-study-of-sdx-7320-in-combination-with-eribulin-for-people-with-breast-cancer-25155https://curecurrent.com/trials/study-of-sacituzumab-govitecan-hziy-and-pembrolizumab-versus-treatment-of-physician-s-choice-in-patients-with-triple-neg-25156https://curecurrent.com/trials/testing-the-addition-of-an-individualized-vaccine-to-durvalumab-and-tremelimumab-and-chemotherapy-in-patients-with-metas-25157https://curecurrent.com/trials/mind-body-group-interventions-for-psychological-distress-in-young-breast-cancer-survivors-25158https://curecurrent.com/trials/study-for-participants-continuing-from-pfizer-sponsored-palbociclib-a-study-medicine-studies-25159https://curecurrent.com/trials/a-study-to-evaluate-safety-tolerability-and-preliminary-activity-of-agx101-in-participants-with-advanced-solid-tumors-25160https://curecurrent.com/trials/screening-magnetic-resonance-imaging-of-the-brain-in-patients-with-breast-cancer-25161https://curecurrent.com/trials/improving-exercise-capacity-with-a-tailored-physical-activity-intervention-25162https://curecurrent.com/trials/a-phase-iii-study-of-shr-a1811-injection-with-or-without-pertuzumab-in-her2-positive-recurrent-or-metastatic-breast-canc-25163https://curecurrent.com/trials/stereotactic-brain-directed-radiation-with-or-without-aguix-gadolinium-based-nanoparticles-in-brain-metastases-25164https://curecurrent.com/trials/carboplatin-nivolumab-in-metastatic-triple-negative-breast-cancer-25165https://curecurrent.com/trials/a-trial-to-evaluate-ovarian-suppression-following-subcutaneous-zoladex-10-8-mg-in-premenopausal-women-with-early-stage-a-25166https://curecurrent.com/trials/navigation-interventions-for-patients-with-breast-cancer-and-high-risk-social-determinants-of-health-25167https://curecurrent.com/trials/a-study-of-disitamab-vedotin-in-adults-with-her2-expressing-advanced-breast-cancer-25168https://curecurrent.com/trials/a-study-evaluating-the-feasibility-and-compliance-of-manual-lymphatic-drainage-comparing-indocyanine-green-icg-guided-vs-25169https://curecurrent.com/trials/a-study-of-trastuzumab-rezetecan-in-combination-with-adebrelimab-versus-investigator-s-choice-of-therapy-in-subjects-wit-25170https://curecurrent.com/trials/study-of-abemaciclib-and-elacestrant-in-participants-with-brain-metastasis-due-to-er-her-2-breast-cancer-25171https://curecurrent.com/trials/capivasertib-regulatory-postmarketing-surveillance-in-korea-25172https://curecurrent.com/trials/ct-ai-breast-cancer-opportunistic-screening-health-examination-study-25173https://curecurrent.com/trials/post-marketing-study-for-early-stage-low-risk-breast-cancer-treatment-using-prosense-cryoablation-choice-trial-25174https://curecurrent.com/trials/effectiveness-of-a-tele-rehabilitation-based-exercise-and-self-lymphatic-drainage-program-supported-by-self-management-f-25175https://curecurrent.com/trials/anatomical-landmarks-for-chest-wall-perforators-used-for-partial-breast-reconstruction-25176https://curecurrent.com/trials/novel-cavity-marking-technique-in-breast-cancer-patients-undergoing-breast-conservation-surgery-with-oncoplastic-reconst-25177https://curecurrent.com/trials/rehabilitation-of-cognitive-changes-in-breast-cancer-survivors-25178https://curecurrent.com/trials/effect-of-the-axillary-lymphatic-vein-reflux-ratio-on-postoperative-upper-limb-edema-and-dysfunction-in-breast-cancer-25179https://curecurrent.com/trials/a-phase-1-1b-study-of-iam1363-in-her2-cancers-25180https://curecurrent.com/trials/akkermansia-muciniphila-akk-for-radiation-induced-skin-injury-25181https://curecurrent.com/trials/single-fraction-very-accelerated-partial-breast-irradiation-sfvapbi-25182https://curecurrent.com/trials/rhomboid-intercostal-block-compared-with-thoracic-paravertebral-block-in-breast-cancer-surgeries-25183https://curecurrent.com/trials/dalpiciclib-combined-with-aromatase-inhibitors-and-olmesartan-as-the-first-line-treatment-for-hr-her2-advanced-breast-ca-25184https://curecurrent.com/trials/pyrotinib-for-her2-positive-advanced-breast-cancer-previously-treated-with-trastuzumab-and-pertuzumab-25185https://curecurrent.com/trials/alcohol-breast-cancer-and-metabolism-25186https://curecurrent.com/trials/correlation-between-anc-and-bone-pain-in-breast-cancer-patients-receiving-long-acting-g-csf-25187https://curecurrent.com/trials/mirai-mri-comparing-screening-mri-for-patients-at-high-risk-for-breast-cancer-identified-by-mirai-and-tyrer-cuzick-25188https://curecurrent.com/trials/shortened-duration-of-tamoxifen-25189https://curecurrent.com/trials/safety-and-tolerability-of-tng462-in-patients-with-mtap-deleted-solid-tumors-25190https://curecurrent.com/trials/safety-and-effectiveness-of-mr-guided-focused-ultrasound-surgery-in-the-treatment-of-early-breast-carcinomas-25191https://curecurrent.com/trials/a-phase-iiib-study-to-evaluate-camizestrant-plus-ribociclib-in-er-positive-her2-negative-advanced-breast-cancer-25192https://curecurrent.com/trials/breast-cancer-reasoning-and-activity-intervention-25193https://curecurrent.com/trials/sweden-cancerome-analysis-network-breast-scan-b-coupled-to-psychological-resilience-25194https://curecurrent.com/trials/enpp1-cgas-eg-and-fap-expression-profiles-in-solid-tumors-an-immunohistochemical-study-in-a-vietnamese-cohort-25195https://curecurrent.com/trials/to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-inavolisib-single-agent-in-participants-with-solid-tumors-an-25196https://curecurrent.com/trials/testing-the-addition-of-copanlisib-to-usual-treatment-fulvestrant-and-abemaciclib-in-metastatic-breast-cancer-25197https://curecurrent.com/trials/study-of-exablate-focused-ultrasound-ablation-of-breast-cancer-25198https://curecurrent.com/trials/phase-1-study-of-stro-006-in-adults-with-refractory-solid-tumors-that-are-recurrent-or-metastatic-25199https://curecurrent.com/trials/patient-navigation-for-her2-metastatic-breast-cancer-patients-treated-with-tucatinib-25200https://curecurrent.com/trials/ultrasound-guided-serratus-anterior-plane-block-versus-ultrasound-guided-thoracic-epidural-analgesia-25201https://curecurrent.com/trials/a-study-of-loxo-783-in-patients-with-breast-cancer-other-solid-tumors-25202https://curecurrent.com/trials/eortc-metastatic-breast-cancer-module-development-25203https://curecurrent.com/trials/comparison-of-combined-superficial-and-deep-and-isolated-deep-serratus-anterior-plane-blocks-after-breast-surgery-25204https://curecurrent.com/trials/a-study-of-177lu-lu-a9-0631-and-225ac-ac-a9-0642-with-68ga-ga-a9-6217-or-177lu-lu-a9-0631-imaging-in-grpr-solid-tumors-25205https://curecurrent.com/trials/a-study-of-a-selective-erbb2-inhibitor-cgt4255-in-patients-with-advanced-solid-tumors-25206https://curecurrent.com/trials/study-of-oric-114-in-patients-with-advanced-solid-tumors-harboring-an-egfr-or-her2-alteration-25207https://curecurrent.com/trials/personalized-cancer-vaccine-pcv-strategy-in-triple-negative-breast-cancer-patients-25208https://curecurrent.com/trials/mobile-health-for-adherence-in-breast-cancer-patients-25209https://curecurrent.com/trials/albumin-bound-paclitaxel-combined-with-antiangiogenic-agents-in-first-line-treatment-of-relapsed-or-metastatic-tnbc-25210https://curecurrent.com/trials/ribociclib-belinostat-in-patients-w-metastatic-triple-neg-breast-cancer-recurrent-ovarian-cancer-w-response-prediction-b-25211https://curecurrent.com/trials/dose-expansion-modular-study-to-explore-the-safety-tolerability-and-anti-tumor-activity-of-her3-dxd-monotherapy-and-comb-25212https://curecurrent.com/trials/a-study-of-hb1801-versus-docetaxel-taxotere-in-patients-with-advanced-breast-cancer-25213https://curecurrent.com/trials/the-safety-dosimetry-and-efficacy-of-177lu-inn805-in-patients-with-malignant-solid-tumors-25214https://curecurrent.com/trials/brca-mutations-in-latinas-25215https://curecurrent.com/trials/veliparib-paclitaxel-and-carboplatin-in-treating-patients-with-solid-tumors-that-are-metastatic-or-cannot-be-removed-by-25216https://curecurrent.com/trials/postoperative-analgesic-consumption-after-preoperative-gabapentin-vs-placebo-in-breast-cancer-surgery-25217https://curecurrent.com/trials/study-of-amxt-1501-and-dfmo-in-combination-with-standard-therapies-in-advanced-solid-tumors-25218https://curecurrent.com/trials/digital-tomosynthesis-mammography-and-digital-mammography-in-screening-patients-for-breast-cancer-25219https://curecurrent.com/trials/evaluation-of-thyroid-abnormity-incidence-and-thyroid-toxicity-during-chemotherapy-among-newly-diagnosed-breast-cancer-25220https://curecurrent.com/trials/study-of-nerve-block-pain-management-in-patients-undergoing-a-double-mastectomy-with-immediate-reconstruction-25221https://curecurrent.com/trials/aspirin-in-preventing-recurrence-of-cancer-in-patients-with-her2-negative-stage-ii-iii-breast-cancer-after-chemotherapy-25222https://curecurrent.com/trials/elacestrant-vs-elacestrant-plus-a-cdk4-6-inhibitor-in-patients-with-erpositive-her2-negative-advanced-or-metastatic-brea-25223https://curecurrent.com/trials/study-of-psilocybin-assisted-psychotherapy-to-address-fear-of-recurrence-25224https://curecurrent.com/trials/mtorc1-2-inhibitor-azd2014-or-the-oral-akt-inhibitor-azd5363-for-recurrent-endometrial-and-ovarian-25225https://curecurrent.com/trials/testing-the-combination-of-two-anti-cancer-drugs-ds-8201a-and-azd6738-for-the-treatment-of-advanced-solid-tumors-express-25226https://curecurrent.com/trials/palbociclib-for-hr-positive-her2-negative-isolated-locoregional-recurrence-of-breast-cancer-25227https://curecurrent.com/trials/platform-study-of-adc-rechallenge-in-adc-treated-metastatic-breast-cancer-25228https://curecurrent.com/trials/ultra-hypo-fractionated-adjuvant-whole-breast-radiation-therapy-with-simultaneous-integrated-boost-for-early-stage-breas-25229https://curecurrent.com/trials/use-of-an-interactive-3d-tool-during-consultation-for-breast-reconstruction-surgery-25230https://curecurrent.com/trials/hypofractionated-radiotherapy-before-or-after-breast-surgery-for-treatment-of-patients-with-non-metastatic-breast-cancer-25231https://curecurrent.com/trials/susan-g-komen-s-shareforcures-25232https://curecurrent.com/trials/trial-of-pre-operative-neratinib-and-endocrine-therapy-with-trastuzumab-in-er-positive-her-2-positive-breast-cancers-25233https://curecurrent.com/trials/a-study-evaluating-the-efficacy-and-safety-of-adjuvant-atezolizumab-or-placebo-and-trastuzumab-emtansine-for-participant-25234https://curecurrent.com/trials/dose-escalation-of-mnpr-101-pcta-177lu-in-solid-tumors-25235https://curecurrent.com/trials/toci-soc-chemo-for-metastatic-triple-negative-and-er-positive-her2-negative-breast-cancers-25236https://curecurrent.com/trials/pet-dynamics-to-response-adapted-neoadjuvant-therapy-in-tnbc-25237https://curecurrent.com/trials/testing-laser-therapy-for-treatment-of-vaginal-dryness-in-survivors-of-breast-cancer-the-revitalize-trial-25238https://curecurrent.com/trials/observational-study-of-bone-complications-in-people-with-post-menopausal-breast-cancer-who-have-stopped-treatment-with-d-25239https://curecurrent.com/trials/diagnostic-efficacy-and-dosimetry-of-mnpr-101-dfo-89zr-in-patients-with-solid-tumors-25240https://curecurrent.com/trials/adding-capivasertib-to-standard-treatment-in-hr-positive-her2-negative-metastatic-breast-cancer-based-on-ctdna-testing-25241https://curecurrent.com/trials/time-restricted-eating-for-the-improvement-of-outcomes-in-patients-with-stage-i-iii-breast-cancer-receiving-chemotherapy-25242https://curecurrent.com/trials/hypofractionated-vs-conventional-fractionated-postmastectomy-radiotherapy-for-high-risk-breast-cancer-25243https://curecurrent.com/trials/a-study-of-t-dxd-as-monotherapy-or-in-combination-with-anti-cancer-agents-in-patients-with-selected-her2-expressing-tumo-25244https://curecurrent.com/trials/the-effect-of-self-management-interventions-among-patients-with-breast-cancer-related-lymphedema-25245https://curecurrent.com/trials/a-novel-patient-decision-aid-for-surgical-treatment-options-in-early-stage-breast-cancer-25246https://curecurrent.com/trials/innovative-and-cooperative-pathway-integrating-oncogeriatric-pharmaceutical-and-pharmacological-follow-up-in-elderly-pat-25247https://curecurrent.com/trials/adjuvant-treatment-in-premenopausal-breast-cancer-25248https://curecurrent.com/trials/trial-of-trastuzumab-deruxtecan-in-previously-treated-her2-25249https://curecurrent.com/trials/radiotherapy-and-long-term-outcomes-in-early-breast-cancer-with-slnb-omission-25250https://curecurrent.com/trials/primary-breast-oligoprogressive-sites-treated-with-radiotherapy-to-obviate-the-need-to-change-systemic-therapy-25251https://curecurrent.com/trials/observational-study-evaluate-pathology-practice-use-artificial-intelligence-in-patient-suspected-lung-and-breast-cancer-25252https://curecurrent.com/trials/cardiometabolic-screening-program-25253https://curecurrent.com/trials/neoadjuvant-endocrine-therapy-combined-with-chemotherapy-in-er-positive-her2-negative-stage-i-iii-breast-cancer-25254https://curecurrent.com/trials/evaluating-minimal-residual-disease-mrd-through-longitudinal-circulating-tumor-dna-ctdna-profiling-in-breast-malignancie-25255https://curecurrent.com/trials/dose-escalation-and-expansion-study-of-flx475-monotherapy-and-in-combination-with-pembrolizumab-25256https://curecurrent.com/trials/improving-cognitive-function-through-high-intensity-interval-training-in-breast-cancer-patients-undergoing-chemotherapy-25257https://curecurrent.com/trials/messages-that-motivate-communicating-alcohol-related-breast-cancer-risk-to-young-adult-women-25258https://curecurrent.com/trials/tactive-u-a-study-to-learn-about-the-study-medicine-vepdegestrant-when-given-with-other-medicines-in-people-with-advance-25259https://curecurrent.com/trials/a-study-of-sns-101-anti-vista-monotherapy-and-in-combination-with-cemiplimab-in-patients-with-advanced-solid-tumors-25260https://curecurrent.com/trials/shortening-adjuvant-photon-and-proton-irradiation-sapphire-ii-a-4-cohort-randomized-phase-ii-multi-center-trial-evaluati-25261https://curecurrent.com/trials/improving-survival-for-metastatic-lobular-breast-cancer-plumb-registry-25262https://curecurrent.com/trials/the-differential-impact-of-proton-beam-irradiation-versus-conventional-radiation-on-organs-at-risk-in-stage-ii-iii-breas-25263https://curecurrent.com/trials/electroacupuncture-vs-auricular-acupressure-vs-waitlist-control-for-breast-cancer-endocrine-therapy-related-joint-pain-25264https://curecurrent.com/trials/phase-ib-study-of-axatilimab-in-combination-with-olaparib-in-brca1-2-and-palb2-associated-metastatic-her2-negative-breas-25265https://curecurrent.com/trials/negative-low-hormone-receptor-and-or-her2-positive-lobular-invasive-breast-carcinoma-a-real-world-international-cohort-s-25266https://curecurrent.com/trials/breast-cancer-weight-loss-study-bwel-study-25267https://curecurrent.com/trials/study-of-the-bria-imt-regimen-and-cpi-vs-physicians-choice-in-advanced-metastatic-breast-cancer-25268https://curecurrent.com/trials/phase-i-trial-of-endoxifen-gel-versus-placebo-in-women-undergoing-breast-surgery-25269https://curecurrent.com/trials/anti-her2-bispecific-antibody-zanidatamab-zw25-activity-in-combination-with-chemotherapy-with-without-tislelizumab-25270https://curecurrent.com/trials/testing-low-dose-tamoxifen-for-invasive-breast-cancer-lotam-trial-25271https://curecurrent.com/trials/assessing-the-immunogenicity-of-ping-hher3fl-25272https://curecurrent.com/trials/omitting-sentinel-node-procedure-in-breast-cancer-patients-undergoing-breast-conserving-therapy-25273https://curecurrent.com/trials/minoxidil-with-or-without-low-level-red-light-therapy-for-improving-chemotherapy-induced-alopecia-in-breast-cancer-patie-25274https://curecurrent.com/trials/study-to-assess-safety-tolerability-and-activity-of-dsb2455-in-participants-with-advanced-malignancies-25275https://curecurrent.com/trials/saruparib-azd5305-plus-camizestrant-or-plus-endocrine-therapy-compared-with-cdk4-6-inhibitor-plus-endocrine-therapy-or-p-25276https://curecurrent.com/trials/trial-on-the-endocrine-activity-of-neoadjuvant-degarelix-25277https://curecurrent.com/trials/ireland-trial-a-translational-biomarker-and-exercise-study-during-neoadjuvant-breast-cancer-therapy-25278https://curecurrent.com/trials/evaluation-of-sequencing-of-anthracyclines-and-taxanes-for-locally-advanced-her2-negative-breast-cancer-25279https://curecurrent.com/trials/opioid-free-versus-opioid-based-anesthesia-in-modified-radical-mastectomy-25280https://curecurrent.com/trials/a-study-of-radiation-therapy-to-treat-solid-tumor-cancer-that-has-spread-to-soft-tissue-25281https://curecurrent.com/trials/molecular-residual-disease-assessment-in-a-representative-diverse-population-of-patients-with-early-stage-breast-cancer-25282https://curecurrent.com/trials/schedules-of-nab-paclitaxel-in-metastatic-breast-cancer-25283https://curecurrent.com/trials/ovarian-sparing-adaptive-radiotherapy-in-young-adult-women-25284https://curecurrent.com/trials/ft836-with-or-without-chemotherapy-and-or-monoclonal-antibodies-in-participants-with-advanced-solid-tumors-25285https://curecurrent.com/trials/a-study-to-determine-the-safety-tolerability-pharmacokinetics-and-preliminary-efficacy-of-abbv-927-with-abbv-368-budigal-25286https://curecurrent.com/trials/evaluating-the-addition-of-adjuvant-chemotherapy-to-ovarian-function-suppression-plus-endocrine-therapy-in-premenopausal-25287https://curecurrent.com/trials/a-study-of-asp2998-given-by-itself-and-given-with-standard-therapies-in-people-with-solid-tumors-25288https://curecurrent.com/trials/kortuc-phase-ii-intra-tumoural-radiation-sensitizer-in-patients-with-locally-advanced-recurrent-breast-cancer-25289https://curecurrent.com/trials/implementing-a-digital-alcohol-intervention-to-raise-women-s-awareness-of-alcohol-related-breast-cancer-risk-during-rout-25290https://curecurrent.com/trials/first-in-human-study-of-ds-1062a-for-advanced-solid-tumors-tropion-pantumor01-25291https://curecurrent.com/trials/regional-radiotherapy-omission-in-low-risk-node-positive-breast-cancer-25292https://curecurrent.com/trials/serratus-posterior-superior-intercostal-plane-block-for-postoperative-analgesia-in-mastectomy-25293https://curecurrent.com/trials/ultrasound-guided-spsip-versus-espb-for-postoperative-pain-after-modified-radical-mastectomy-25294https://curecurrent.com/trials/brain-avoidant-proton-craniospinal-irradiation-for-leptomeningeal-metastases-from-solid-tumor-malignancies-25295https://curecurrent.com/trials/a-multi-modality-surveillance-program-for-women-at-high-risk-for-breast-cancer-25296https://curecurrent.com/trials/personalized-preventive-support-for-cognitive-impairment-in-non-metastatic-breast-cancer-efacog-25297https://curecurrent.com/trials/mri-background-parenchymal-enhancement-as-a-risk-factor-for-breast-cancer-the-imaging-and-epidemiology-imagine-study-25298https://curecurrent.com/trials/cosegregation-of-variants-in-panel-of-genes-25299https://curecurrent.com/trials/safety-extension-study-for-subjects-with-hr-her2-breast-cancer-for-subjects-who-have-completed-the-ovelia-study-25300https://curecurrent.com/trials/4-3-intermittent-fasting-intervention-in-adults-with-breast-cancer-and-overweight-or-obesity-25301https://curecurrent.com/trials/letrozole-in-preventing-cancer-in-postmenopausal-women-who-have-received-4-6-years-of-hormone-therapy-for-hormone-recept-25302https://curecurrent.com/trials/neoadjuvant-pyrotinib-to-pertuzumab-in-her2-ebc-25303https://curecurrent.com/trials/immediate-autologous-tissue-breast-reconstruction-and-radiotherapy-strategy-after-breast-cancer-surgery-25304https://curecurrent.com/trials/a-phase-1a-1b-first-time-in-human-study-of-ct-202-a-nectin-4-directed-bispecific-antibody-in-participants-with-recurring-25305https://curecurrent.com/trials/fluorescence-for-sentinel-lymph-node-identification-in-cancer-surgery-25306https://curecurrent.com/trials/is-dietary-nitrate-effective-in-reducing-aerobic-glycolysis-in-breast-cancer-25307https://curecurrent.com/trials/rintatolimod-celecoxib-and-interferon-alpha-2b-with-pembrolizumab-for-the-treatment-of-patients-with-metastatic-or-unres-25308https://curecurrent.com/trials/study-of-18f-ffnp-breast-pet-mri-25309https://curecurrent.com/trials/towards-early-detection-of-breast-cancer-in-high-risk-population-25310https://curecurrent.com/trials/promoting-informed-choice-for-breast-cancer-screening-a-longitudinal-study-25311https://curecurrent.com/trials/exercise-treatment-with-standard-therapy-for-metastatic-breast-cancer-25312https://curecurrent.com/trials/a-study-of-dato-dxd-in-chinese-patients-with-advanced-non-small-cell-lung-cancer-triple-negative-breast-cancer-and-other-25313https://curecurrent.com/trials/environmental-exposure-assessment-in-high-risk-and-early-onset-breast-cancer-care-25314https://curecurrent.com/trials/culmerciclib-combined-with-letrozole-and-dual-her2-blockade-as-neoadjuvant-therapy-for-hr-her2-breast-cancer-25315https://curecurrent.com/trials/preoperative-fulvestrant-with-or-without-enzalutamide-in-er-her2-breast-cancer-25316https://curecurrent.com/trials/testing-mk-3475-pembrolizumab-as-adjuvant-therapy-for-triple-receptor-negative-breast-cancer-25317https://curecurrent.com/trials/proagio-in-combination-with-gemcitabine-in-patients-with-metastatic-triple-negative-breast-cancer-25318https://curecurrent.com/trials/neoadjuvant-endocrine-therapy-in-er-positive-her2-negative-early-stage-breast-cancer-25319https://curecurrent.com/trials/pilot-smart-of-a-remotely-delivered-physical-activity-intervention-for-breast-cancer-survivors-25320https://curecurrent.com/trials/a-study-of-oral-mbq-167-in-participants-with-advanced-breast-cancer-25321https://curecurrent.com/trials/comparison-of-axillary-lymph-node-dissection-with-axillary-radiation-for-patients-with-node-positive-breast-cancer-treat-25322https://curecurrent.com/trials/creation-and-implementation-a-method-for-breast-reconstruction-after-radical-surgery-using-decellularized-xenomatrix-in-25323https://curecurrent.com/trials/radiation-omission-in-patients-with-clinically-node-negative-breast-cancer-undergoing-lumpectomy-25324https://curecurrent.com/trials/evaluation-of-the-distribution-of-64cu-68ga-labeled-cm500-in-healthy-volunteers-and-patients-with-cancer-25325https://curecurrent.com/trials/testing-olaparib-either-alone-or-in-combination-with-atezolizumab-in-brca-mutant-non-her2-positive-breast-cancer-25326https://curecurrent.com/trials/slnb-combined-with-wlnb-for-axillary-de-escalation-in-breast-cancer-patients-with-abnormal-axillary-nodes-25327https://curecurrent.com/trials/a-study-of-dm001-in-patients-with-advanced-solid-tumors-25328https://curecurrent.com/trials/tucatinib-continuation-study-25329https://curecurrent.com/trials/herbs-supplements-in-breast-cancer-usage-impact-and-personalized-approaches-for-diverse-populations-25330https://curecurrent.com/trials/effects-of-risk-presentation-format-and-frequently-asked-questions-on-breast-cancer-risk-skepticism-25331https://curecurrent.com/trials/mrna-therapy-to-restore-lymphatic-flow-in-secondary-lymphedema-25332https://curecurrent.com/trials/preoperative-lenvatinib-plus-pembrolizumab-in-early-stage-triple-negative-breast-cancer-tnbc-25333https://curecurrent.com/trials/study-of-belzutifan-mk-6482-plus-fulvestrant-for-er-her2-metastatic-breast-cancer-mk-6482-029-litespark-029-25334https://curecurrent.com/trials/skb264-kl-a167-in-recurrent-or-metastatic-her2-negative-breast-cancer-25335https://curecurrent.com/trials/tamoxifen-citrate-or-letrozole-with-or-without-bevacizumab-in-treating-women-with-stage-iiib-or-stage-iv-breast-cancer-25336https://curecurrent.com/trials/a-study-with-nkt5097-for-adults-with-advanced-metastatic-solid-tumors-25337https://curecurrent.com/trials/s0221-adjuvant-doxorubicin-cyclophosphamide-and-paclitaxel-in-treating-patients-with-breast-cancer-25338https://curecurrent.com/trials/impact-of-vitamin-d-supplementation-on-the-rate-of-pathologic-complete-response-in-vitamin-d-deficient-patients-25339https://curecurrent.com/trials/system-integrated-point-of-care-ultrasound-in-breast-cancer-screening-25340https://curecurrent.com/trials/testing-the-safety-of-the-anti-cancer-drug-sn-117m-dtpa-for-advanced-cancers-that-have-spread-to-bones-25341https://curecurrent.com/trials/tamoxifen-citrate-or-z-endoxifen-hydrochloride-in-treating-patients-with-locally-advanced-or-metastatic-estrogen-recepto-25342https://curecurrent.com/trials/classifying-for-her2-dependence-to-de-escalate-neoadjuvant-chemotherapy-in-patients-with-her2-early-breast-cancer-underg-25343https://curecurrent.com/trials/multi-institutional-transgender-gender-diverse-breast-cancer-study-25344https://curecurrent.com/trials/rowing-following-breast-cancer-chemotherapy-25345https://curecurrent.com/trials/study-of-177lu-lu-dwj155-and-68ga-ga-dwj155-in-patients-with-solid-tumors-25346https://curecurrent.com/trials/integrating-molecular-pathology-radiology-and-genetics-to-improve-breast-cancer-risk-25347https://curecurrent.com/trials/a-study-to-evaluate-genetic-predictors-of-aromatase-inhibitor-musculoskeletal-symptoms-aimss-25348https://curecurrent.com/trials/researching-the-effect-of-exercise-on-cancer-25349https://curecurrent.com/trials/her2-vaccine-for-locally-advanced-breast-cancer-25350https://curecurrent.com/trials/sweden-cancerome-analysis-network-breast-genomic-profiling-of-breast-cancer-25351https://curecurrent.com/trials/study-of-eci830-single-agent-or-in-combination-in-patients-with-advanced-hr-her2-breast-cancer-and-in-patients-with-othe-25352https://curecurrent.com/trials/her-2-b-cell-peptide-vaccine-25353https://curecurrent.com/trials/a-study-of-h3b-6545-in-combination-with-palbociclib-in-women-with-advanced-or-metastatic-estrogen-receptor-positive-huma-25354https://curecurrent.com/trials/phase-i-dose-escalation-of-single-fraction-adjuvant-stereotactic-body-partial-breast-irradiation-early-stage-breast-ca-25355https://curecurrent.com/trials/is-lipid-mapping-an-effective-early-detection-tool-for-breast-cancer-in-high-risk-populations-25356https://curecurrent.com/trials/safety-pk-and-efficacy-of-qxl138am-in-patients-with-solid-tumors-and-multiple-myeloma-25357https://curecurrent.com/trials/developing-and-testing-the-efficacy-of-ai-chatbot-based-25358https://curecurrent.com/trials/tablet-based-mobile-health-ultrasound-for-point-of-care-breast-cancer-diagnosis-in-nigeria-25359https://curecurrent.com/trials/a-phase-1-2a-study-of-db-1303-bnt323-in-advanced-metastatic-solid-tumors-25360https://curecurrent.com/trials/a-phase-i-study-of-rgt-419b-in-patients-with-hr-positive-her2-negative-advanced-breast-cancer-or-other-solid-tumors-25361https://curecurrent.com/trials/a-study-of-bl-b01d1-in-patients-with-unresectable-locally-advanced-or-metastatic-breast-cancer-and-other-solid-tumors-25362https://curecurrent.com/trials/a-study-of-bl-m07d1-in-patients-with-locally-advanced-or-metastatic-her2-positive-negative-breast-cancer-and-other-solid-25363https://curecurrent.com/trials/study-of-aerobic-training-for-people-receiving-treatment-for-breast-cancer-25364https://curecurrent.com/trials/radiotherapy-with-extreme-hypofractionation-in-patients-with-breast-cancer-in-brazil-a-retrospective-cohort-study-25365https://curecurrent.com/trials/a-phase-i-study-of-68ga-ga-dwj155-in-patients-with-breast-and-lung-cancers-25366https://curecurrent.com/trials/phase-i-study-of-jfi447-68ga-ga-dfc413-and-comparison-to-ffg233-68ga-ga-nns309-in-patients-with-solid-tumors-25367https://curecurrent.com/trials/suppression-of-ovarian-function-with-either-tamoxifen-or-exemestane-compared-with-tamoxifen-alone-in-treating-premenopau-25368https://curecurrent.com/trials/different-localization-techniques-for-non-palpable-breast-lesions-comparison-a-retrospective-and-multicentric-clinical-s-25369https://curecurrent.com/trials/palbociclib-in-molecularly-characterized-er-positive-her2-negative-metastatic-breast-cancer-25370https://curecurrent.com/trials/improving-communication-and-adherence-in-black-breast-cancer-survivors-sisters-informing-sisters-25371https://curecurrent.com/trials/exercise-therapy-to-improve-cardiovascular-health-in-post-menopausal-women-after-treatment-for-early-stage-breast-cancer-25372https://curecurrent.com/trials/sacituzumab-govitecan-and-q901-in-advanced-tnbc-25373https://curecurrent.com/trials/a-ph-ii-study-of-the-therabionic-p1-device-in-subjects-with-hormone-positive-breast-cancer-25374https://curecurrent.com/trials/stand-up-to-cancer-magenta-making-genetic-testing-accessible-25375https://curecurrent.com/trials/desloratadine-to-prevent-taxane-induced-peripheral-neuropathy-in-patients-with-breast-cancer-25376https://curecurrent.com/trials/phii-randomized-capecitabine-elacestrant-vs-capecitabine-alone-in-er-breast-cancer-capela-25377https://curecurrent.com/trials/karma-kontrast-evaluating-contrast-enhanced-mammography-in-early-detection-of-breast-cancer-25378https://curecurrent.com/trials/safety-efficacy-study-of-cid-078-in-patients-with-advanced-solid-tumor-malignancies-25379https://curecurrent.com/trials/treatment-of-adc-refractory-breast-cancer-with-dato-dxd-or-t-dxd-trade-dxd-25380https://curecurrent.com/trials/a-study-to-investigate-efficacy-and-safety-with-oral-azd9833-compared-with-intramuscular-fulvestrant-in-post-menopausal-25381https://curecurrent.com/trials/breast-cancer-patient-engagement-with-patient-reported-outcome-measure-survey-25382https://curecurrent.com/trials/molecular-imaging-of-epcam-expression-in-breast-cancer-using-99mtc-tc-darpinec1-g3c-25383https://curecurrent.com/trials/evaluation-of-novel-cone-beam-ct-for-guidance-and-adaptation-of-precision-radiotherapy-25384https://curecurrent.com/trials/prospective-observational-study-for-breast-microcalcifications-classification-with-artificial-intelligence-techniques-25385https://curecurrent.com/trials/characterization-of-extracellular-vesicles-in-breast-cancer-patients-25386https://curecurrent.com/trials/single-vs-hypofractionated-irradiation-for-timely-access-to-partial-breast-radiotherapy-25387https://curecurrent.com/trials/tailored-neoadjuvant-chemoimmunotherapy-for-stage-i-tnbc-25388https://curecurrent.com/trials/comparison-of-the-efficacy-and-safety-of-mirogabalin-and-duloxetine-in-chemotherapy-induced-peripheral-neuropathy-in-a-r-25389https://curecurrent.com/trials/multi-4scar-t-therapy-targeting-breast-cancer-25390https://curecurrent.com/trials/ql1706-plus-neoadjuvant-endocrine-therapy-in-hr-positive-her2-negative-breast-cancer-with-a-poor-response-to-neoadjuvant-25391https://curecurrent.com/trials/to-reduce-the-use-of-chemotherapy-in-postmenopausal-patients-with-er-positive-and-her2-positive-breast-cancer-touch-25392https://curecurrent.com/trials/onco-genomas-brasil-mapping-breast-and-prostate-cancer-in-the-brazilian-public-health-system-25393https://curecurrent.com/trials/shr-a1811-monotherapy-or-sequential-thpy-as-neoadjuvant-therapy-for-stage-ii-iii-her2-positive-breast-cancer-25394https://curecurrent.com/trials/prolonged-overnight-fasting-and-or-exercise-on-fatigue-and-other-patient-reported-outcomes-in-women-with-hormone-recepto-25395https://curecurrent.com/trials/a-study-of-bl-m07d1-with-or-without-pertuzumab-versus-docetaxel-carboplatin-trastuzumab-pertuzumab-in-neoadjuvant-therap-25396https://curecurrent.com/trials/a-study-of-mutant-selective-inhibitor-cgt6297-in-patients-with-advanced-solid-tumors-25397https://curecurrent.com/trials/a-study-to-estimate-effect-of-formulation-and-food-on-relative-bioavailability-of-hrs-6209-in-healthy-participants-25398https://curecurrent.com/trials/rhomboid-intercostal-block-with-sub-serratus-plane-block-versus-erector-spinae-block-25399https://curecurrent.com/trials/kk-lc-1-tcr-t-cell-therapy-for-gastric-breast-cervical-and-lung-cancer-25400https://curecurrent.com/trials/basket-study-of-entrectinib-rxdx-101-for-the-treatment-of-patients-with-solid-tumors-harboring-ntrk-1-2-3-trk-a-b-c-ros1-25401https://curecurrent.com/trials/jyp0035-capsules-plus-fulvestrant-in-pik3ca-mutant-hr-her2-advanced-breast-cancer-25402https://curecurrent.com/trials/biomarkers-to-detect-endocrine-therapy-resistance-25403https://curecurrent.com/trials/nuvastatic-phase-iii-trial-for-fatigue-in-triple-negative-breast-cancer-25404https://curecurrent.com/trials/improving-patient-and-caregiver-understanding-of-risks-and-benefits-of-immunotherapy-for-advanced-cancer-25405https://curecurrent.com/trials/a-prospective-observational-study-to-describe-clinical-outcomes-treatment-patterns-patients-characteristics-among-patien-25406https://curecurrent.com/trials/z-endoxifen-hydrochloride-in-treating-patients-with-metastatic-or-locally-recurrent-estrogen-receptor-positive-breast-ca-25407https://curecurrent.com/trials/study-of-trastuzumab-deruxtecan-t-dxd-in-combination-with-a-rage-inhibitor-in-patients-with-t-dxd-resistant-her2-positiv-25408https://curecurrent.com/trials/immersive-meditation-for-managing-preoperative-distress-25409https://curecurrent.com/trials/rebecca-real-world-early-breast-cancer-management-25410https://curecurrent.com/trials/dietary-mimicry-by-glucocorticoid-modulation-evaluation-in-er-metastatic-breast-cancer-treatment-efficacy-and-response-d-25411https://curecurrent.com/trials/collecting-and-storing-tissue-samples-from-women-with-or-without-breast-cancer-25412https://curecurrent.com/trials/study-of-chemotherapy-plus-ipatasertib-for-people-with-solid-tumors-with-pten-akt-mutations-a-combomatch-treatment-trial-25413https://curecurrent.com/trials/study-to-assess-adverse-events-and-change-in-disease-activity-in-adult-participants-with-select-advanced-solid-tumor-ind-25414https://curecurrent.com/trials/4scar-cd44v6-t-cell-therapy-targeting-cancer-25415https://curecurrent.com/trials/a-phase-2-single-arm-open-label-pilot-trial-evaluating-zanidatamab-zw25-in-patients-with-early-stage-her2-neu-positive-h-25416https://curecurrent.com/trials/a-phase-ii-study-of-biomarker-guided-de-escalation-using-anthracycline-free-neoadjuvant-chemoimmunotherapy-in-early-stag-25417https://curecurrent.com/trials/functional-precision-oncology-to-predict-prevent-and-treat-early-metastatic-recurrence-of-tnbc-25418https://curecurrent.com/trials/ethan-et-for-male-bc-25419https://curecurrent.com/trials/efficacy-of-tramadol-with-ropivacaine-for-modified-pectoral-nerve-block-in-breast-cancer-surgery-25420https://curecurrent.com/trials/quality-of-life-for-patients-with-breast-cancer-brain-metastases-and-leptomeningeal-disease-25421https://curecurrent.com/trials/multimodal-assessment-of-cryotherapy-for-paclitaxel-induced-neuropathy-25422https://curecurrent.com/trials/a-study-of-t-dxd-in-ai-assessed-her2-ultralow-metastatic-breast-cancer-25423https://curecurrent.com/trials/bre-06-study-to-increase-tolerance-to-aromatase-inhibitors-for-patients-with-early-stage-hormone-receptor-positive-breas-25424https://curecurrent.com/trials/a-phase-3-open-label-randomized-study-of-dato-dxd-versus-investigator-s-choice-of-chemotherapy-icc-in-participants-with-25425https://curecurrent.com/trials/elacestrant-everolimus-in-patients-er-her2-esr1mut-advanced-breast-cancer-progressing-to-et-and-cdk4-6i-25426https://curecurrent.com/trials/mindvybe-tvns-aps-for-wellbeing-in-breast-cancer-survivors-25427https://curecurrent.com/trials/evaluation-of-the-safety-and-efficacy-of-single-port-robot-assisted-endoscopic-breast-conserving-surgery-and-nipple-spar-25428https://curecurrent.com/trials/prospective-metastases-imaging-poem-25429https://curecurrent.com/trials/tdxd-in-metastatic-her2-positive-breast-cancer-25430https://curecurrent.com/trials/a-first-in-human-study-of-hh160-in-participants-with-advanced-or-metastatic-solid-tumors-25431https://curecurrent.com/trials/gut-microbiome-adverse-effects-and-markers-through-metabolic-reprogramming-25432https://curecurrent.com/trials/a-single-arm-phase-study-of-fluzoparib-maintenance-in-platinum-sensitive-advanced-triple-negative-breast-cance-25433https://curecurrent.com/trials/a-phase-1-trial-of-zn-a-1041-enteric-capsules-or-combination-in-participants-with-human-epidermal-growth-factor-receptor-25434https://curecurrent.com/trials/using-an-end-of-life-conversation-game-to-engage-patients-with-cancer-in-advance-care-planning-phase-2-25435https://curecurrent.com/trials/bre-10-biomarker-optimization-of-neoadjuvant-therapy-in-breast-cancer-25436https://curecurrent.com/trials/a-study-to-evaluate-the-safety-pharmacokinetics-and-activity-of-gdc-0587-as-a-monotherapy-and-in-combination-with-girede-25437https://curecurrent.com/trials/effect-of-aromatherapy-on-the-management-of-chemotherapy-induced-neuropathy-cin-25438https://curecurrent.com/trials/a-pivotal-phase-ii-clinical-trial-of-utidelone-injection-plus-capecitabine-in-her2-negative-breast-cancer-patients-with-25439https://curecurrent.com/trials/pavement-palbociclib-and-avelumab-in-metastatic-ar-triple-negative-breast-cancer-25440https://curecurrent.com/trials/atezolizumab-pertuzumab-trastuzumab-in-cns-mets-in-bc-25441https://curecurrent.com/trials/the-association-between-cbt-i-dose-sleep-duration-and-fatigue-in-breast-cancer-patients-25442https://curecurrent.com/trials/axillary-web-syndrome-after-breast-cancer-surgery-incidence-risk-factors-and-functional-outcomes-25443https://curecurrent.com/trials/application-of-single-port-robot-assisted-breast-conserving-surgery-via-axillary-approach-for-breast-cancer-25444https://curecurrent.com/trials/experimental-pet-imaging-scans-before-cancer-surgery-to-study-the-amount-of-pet-tracer-accumulated-in-normal-and-cancer-25445https://curecurrent.com/trials/culturally-based-brief-expressive-writing-intervention-for-the-improvement-of-health-in-chinese-immigrant-stage-0-iii-br-25446https://curecurrent.com/trials/a-synthetic-lethality-focused-algorithm-to-identify-therapeutic-options-in-advanced-metastatic-breast-cancer-synthesis-b-25447https://curecurrent.com/trials/study-of-high-precision-evaluation-of-molecular-residual-disease-through-a-platform-for-cancer-tracking-and-interception-25448https://curecurrent.com/trials/autologous-fat-grafting-for-total-breast-reconstruction-in-irradiated-breast-cancer-patients-25449https://curecurrent.com/trials/a-phase-1-study-of-lncb74-in-advanced-solid-tumors-25450https://curecurrent.com/trials/basket-study-of-tucatinib-and-trastuzumab-in-solid-tumors-with-her2-alterations-25451https://curecurrent.com/trials/herizon-breast-a-ctdna-guided-adaptive-study-of-sequential-anti-her2-therapies-and-cns-prophylaxis-to-induce-long-term-r-25452https://curecurrent.com/trials/a-study-to-understand-the-patients-confirmed-to-have-advanced-or-metastatic-breast-cancer-and-receiving-palbociclib-trea-25453https://curecurrent.com/trials/nurturing-exercise-routine-for-greater-improvement-in-zest-and-energy-on-enhertu-25454https://curecurrent.com/trials/mindfulness-intervention-for-improving-nutrition-in-the-digital-kitchen-among-stage-i-iii-breast-cancer-survivors-mind-t-25455https://curecurrent.com/trials/a-pilot-study-to-assess-the-clinical-utility-of-pylarify-pet-ct-for-detecting-metastasis-in-pancreatic-cancer-hepatocell-25456https://curecurrent.com/trials/livewell-mbc-adapted-dialectical-behavioral-therapy-skills-training-25457https://curecurrent.com/trials/quantitative-transmission-imaging-compared-with-mri-as-supplemental-screening-for-high-lifetime-risk-of-breast-cancer-25458https://curecurrent.com/trials/study-to-test-the-safety-and-tolerability-of-pf-07220060-in-participants-with-advance-solid-tumors-25459https://curecurrent.com/trials/dosing-physical-activity-among-older-cancer-survivors-who-experience-chronic-pain-a-micro-randomized-trial-25460https://curecurrent.com/trials/a-study-to-learn-about-the-study-medicine-called-pf-07220060-in-combination-with-fulvestrant-in-people-with-hr-positive-25461https://curecurrent.com/trials/her2-molecular-imaging-with-89zr-trastuzumab-pet-ct-as-a-predictive-biomarker-for-antibody-drug-conjugate-sequencing-in-25462https://curecurrent.com/trials/madre-mammograms-available-due-to-research-and-education-25463https://curecurrent.com/trials/niraparib-and-tsr-042-for-the-treatment-of-brca-mutated-unresectable-or-metastatic-breast-pancreas-ovary-fallopian-tube-25464https://curecurrent.com/trials/application-of-ct-linac-based-all-in-one-one-stop-radiotherapy-in-breast-cancer-25465https://curecurrent.com/trials/physical-activity-and-healthy-aging-promoting-cardio-metabolic-capacity-to-fight-chronic-inflammation-and-improve-outcom-25466https://curecurrent.com/trials/imlunestrant-and-abemaciclib-for-the-treatment-of-estrogen-receptor-positive-breast-cancer-in-patients-with-minimal-resi-25467https://curecurrent.com/trials/study-of-cbx-12-in-subjects-with-advanced-or-metastatic-refractory-solid-tumors-25468https://curecurrent.com/trials/a-teach-back-approach-to-increase-breast-cancer-knowledge-in-women-with-low-health-literacy-an-intervention-study-25469https://curecurrent.com/trials/personalized-neoantigen-peptide-based-vaccine-in-combination-with-pembrolizumab-for-treatment-of-advanced-solid-tumors-25470https://curecurrent.com/trials/a-study-of-romosozumab-in-people-with-breast-cancer-and-osteoporosis-25471https://curecurrent.com/trials/phase-ii-trial-of-trilaciclib-pembrolizumab-gemcitabine-and-carboplatin-in-metastatic-triple-negative-breast-cancer-25472https://curecurrent.com/trials/peer-navigator-education-in-improving-survivorship-care-in-african-american-breast-cancer-survivors-25473https://curecurrent.com/trials/mri-based-preoperative-accelerated-partial-breast-irradiation-25474https://curecurrent.com/trials/study-of-skb103-in-her2-negative-breast-cancer-25475https://curecurrent.com/trials/searching-for-masses-and-calcifications-at-the-same-time-in-breast-cancer-screening-25476https://curecurrent.com/trials/volumetric-specimen-imager-device-for-the-intraoperative-imaging-of-patients-with-breast-carcinoma-and-breast-ductal-car-25477https://curecurrent.com/trials/male-breast-cancer-predisposition-factor-creation-of-a-control-cohort-2-25478https://curecurrent.com/trials/measuring-the-effects-of-talazoparib-in-patients-with-advanced-cancer-and-dna-repair-variations-25479https://curecurrent.com/trials/atempt-2-0-adjuvant-t-dm1-vs-th-25480https://curecurrent.com/trials/akt-inhibitor-ipatasertib-with-endocrine-and-cdk-4-6-inhibitor-for-patients-with-metastatic-breast-cancer-taktic-25481https://curecurrent.com/trials/a-study-to-investigate-safety-of-azd6750-in-adult-participants-with-select-advanced-or-metastatic-solid-tumors-25482https://curecurrent.com/trials/a-study-to-identify-breast-cancer-idbc-25483https://curecurrent.com/trials/optimizing-surgical-decisions-in-young-adults-with-breast-cancer-25484https://curecurrent.com/trials/multiparametric-mri-as-a-non-invasive-biomarker-of-the-tumor-microenviroment-25485https://curecurrent.com/trials/biennial-cem-in-women-with-a-personal-history-of-breast-cancer-25486https://curecurrent.com/trials/clinical-trial-assessing-the-safety-of-neoadjuvant-palbociclib-in-combination-with-endocrine-therapy-25487https://curecurrent.com/trials/home-based-respiratory-muscle-training-for-minimizing-side-effects-in-patients-undergoing-treatment-for-cancer-25488https://curecurrent.com/trials/stage-i-her2-positive-invasive-breast-cancer-de-escalation-study-iris-25489https://curecurrent.com/trials/trial-of-retifanlimab-with-trastuzumab-and-pertuzumab-combination-in-her2-addicted-breast-cancer-25490https://curecurrent.com/trials/abcsg-61-teodor-neoadjuvant-treatment-optimization-driven-by-circulating-tumor-dna-and-endocrine-responsiveness-25491https://curecurrent.com/trials/capecitabine-and-cyclophosphamide-xc-as-maintenance-therapy-for-advanced-breast-cancer-25492https://curecurrent.com/trials/percutaneous-cryoablation-for-the-treatment-of-breast-cancer-25493https://curecurrent.com/trials/decision-support-tool-for-patients-with-advanced-breast-cancer-25494https://curecurrent.com/trials/tai-chi-effects-on-chronic-insomnia-in-breast-cancer-survivors-immune-mechanisms-25495https://curecurrent.com/trials/phase-1b-study-of-trick-nk-in-combination-with-t-dxd-in-treatment-refractory-breast-cancers-25496https://curecurrent.com/trials/byl719-and-letrozole-in-post-menopausal-patients-with-hormone-receptor-positive-metastatic-breast-cancer-25497https://curecurrent.com/trials/study-of-the-kinesin-oral-molecular-degrader-bbi-940-in-subjects-with-advanced-or-metastatic-breast-cancer-25498https://curecurrent.com/trials/destiny-breast-respond-her2-ultra-low-europe-25499https://curecurrent.com/trials/establishment-of-a-multi-omics-prediction-model-for-early-triple-negative-breast-cancer-based-on-upgrade-tnbc-study-25500https://curecurrent.com/trials/large-language-models-to-aid-gynecological-oncology-treatment-25501https://curecurrent.com/trials/survivorship-care-planning-in-improving-the-quality-of-life-in-breast-cancer-survivors-25502https://curecurrent.com/trials/penn-surveillance-markers-of-utility-for-recurrence-after-neo-adjuvant-therapy-for-breast-cancer-25503https://curecurrent.com/trials/self-determination-theory-informed-occupational-therapy-program-to-increase-physical-activity-among-survivors-of-breast-25504https://curecurrent.com/trials/rct-of-cbd-for-anxiety-in-advanced-breast-cancer-25505https://curecurrent.com/trials/serplulimab-combined-with-chemotherapy-for-early-stage-hr-her2-breast-cancer-25506https://curecurrent.com/trials/neoadjuvant-neratinib-in-stage-i-iii-her2-mutated-lobular-breast-cancers-25507https://curecurrent.com/trials/pilot-trial-to-assess-68ga-bombesin-pet-ct-neob-imaging-for-staging-of-breast-cancer-25508https://curecurrent.com/trials/combination-immunotherapy-treatment-for-locally-advanced-unresectable-or-metastatic-pd-l1-negative-cps-10-gbrca-negative-25509https://curecurrent.com/trials/a-study-of-camizestrant-in-er-her2-early-breast-cancer-after-at-least-2-years-of-standard-adjuvant-endocrine-therapy-25510https://curecurrent.com/trials/study-of-the-chk1-inhibitor-bbi-355-an-ecdna-directed-therapy-ecdtx-and-the-rnr-inhibitor-bbi-825-in-subjects-with-tumor-25511https://curecurrent.com/trials/study-of-the-intra-patient-variability-of-the-quantitative-parameters-of-tumor-perfusion-evaluated-with-ultrasound-contr-25512https://curecurrent.com/trials/michigan-genetic-hereditary-testing-might-25513https://curecurrent.com/trials/paclitaxel-polymeric-micelles-and-carboplatin-in-combination-with-iparomilimab-and-tuvonralimab-neoadjuvant-therapy-for-25514https://curecurrent.com/trials/romiplostim-n01-for-injection-for-secondary-prophylaxis-of-cit-in-breast-cancer-25515https://curecurrent.com/trials/long-term-safety-of-nipple-sparing-mastectomy-in-women-with-high-penetrance-breast-cancer-susceptibility-genes-in-breast-25516https://curecurrent.com/trials/adapting-a-mammography-decision-aid-to-support-women-living-in-a-community-contaminated-by-pfas-25517https://curecurrent.com/trials/a-study-of-bebt-209-plus-chemotherapy-in-patients-with-locally-advanced-or-metastatic-triple-negative-breast-cancer-25518https://curecurrent.com/trials/impact-of-intermittent-and-water-only-fasting-on-gene-expression-and-tumor-markers-in-breast-cancer-25519https://curecurrent.com/trials/immunologic-targeting-of-esr1-receptor-for-hormone-receptor-expressing-metastatic-breast-cancer-25520https://curecurrent.com/trials/real-world-study-of-skb264-monotherapy-or-combination-therapy-in-recurrent-or-metastatic-her2-negative-breast-cancer-25521https://curecurrent.com/trials/phase-i-study-of-bebt-209-in-women-with-advanced-breast-cancer-25522https://curecurrent.com/trials/a-study-of-bebt-209-in-combination-with-chemotherapy-for-the-treatment-of-advanced-triple-negative-breast-cancer-25523https://curecurrent.com/trials/neoadjuvant-pyrotinib-in-hr-positive-and-her2-low-high-risk-early-breast-cancer-25524https://curecurrent.com/trials/study-of-azd9833-alone-or-in-combination-in-women-with-advanced-breast-cancer-25525https://curecurrent.com/trials/a-phase-1-study-of-nrm-823-in-participants-with-locally-advanced-or-metastatic-refractory-solid-tumors-25526https://curecurrent.com/trials/a-novel-approach-utilizing-organ-specific-age-proteomics-25527https://curecurrent.com/trials/triple-negative-breast-cancer-and-germline-hereditary-breast-and-ovarian-cancer-mutation-carrier-registry-25528https://curecurrent.com/trials/a-phase-i-trial-of-ly3143921-hydrate-in-solid-tumours-25529https://curecurrent.com/trials/capecitabine-in-er-her2-negative-breast-cancer-25530https://curecurrent.com/trials/prototype-daa-taa-vaccine-targeting-muc1-for-immune-interception-and-prevention-in-ductal-carcinoma-in-situ-25531https://curecurrent.com/trials/monitoring-breast-cancer-immunotherapy-treatment-with-advanced-positron-emission-tomography-magnetic-resonance-imaging-p-25532https://curecurrent.com/trials/omission-of-axillary-lymph-node-dissection-in-case-of-tumor-spread-to-lymph-nodes-in-the-armpit-in-breast-cancer-25533https://curecurrent.com/trials/a-study-of-evaluating-the-effects-of-pyrotinib-after-adjuvant-trastuzumab-in-women-with-early-stage-breast-cancer-25534https://curecurrent.com/trials/telemedicine-mhealth-symptom-cluster-intervention-for-advanced-cancer-patients-finding-our-center-under-stress-focus-25535https://curecurrent.com/trials/research-on-the-development-and-validation-of-personalized-exercise-prescription-system-for-breast-cancer-patients-based-25536https://curecurrent.com/trials/an-open-label-study-to-enable-continued-treatment-access-for-subjects-previously-enrolled-in-studies-of-ruxolitinib-25537https://curecurrent.com/trials/exert-bc-cardio-cardio-or-conditioning-training-with-breast-cancer-25538https://curecurrent.com/trials/feasibility-of-exercise-for-cancer-patients-and-healthy-eating-timeframes-25539https://curecurrent.com/trials/identification-of-early-markers-of-response-and-resistance-to-trastuzumab-25540https://curecurrent.com/trials/capivasertib-fulvestrant-astreatment-for-locally-advanced-inoperable-or-metastatic-hr-her2-breast-cancer-in-chinese-pati-25541https://curecurrent.com/trials/a-study-of-bms-986340-as-monotherapy-and-as-combination-therapy-in-participants-with-advanced-solid-tumors-25542https://curecurrent.com/trials/inspiratory-muscle-training-in-obese-breast-cancer-survivors-25543https://curecurrent.com/trials/systemic-anti-cancer-therapy-dose-modifications-for-individuals-with-duffy-null-phenotype-25544https://curecurrent.com/trials/a-study-to-describe-the-diagnosis-anti-cancer-treatment-and-clinical-outcome-in-patients-with-newly-diagnosed-breast-can-25545https://curecurrent.com/trials/hypofractionated-radiation-therapy-or-standard-radiation-therapy-in-treating-patients-with-ductal-breast-carcinoma-in-si-25546https://curecurrent.com/trials/a-study-evaluating-the-efficacy-and-safety-of-giredestrant-combined-with-palbociclib-compared-with-letrozole-combined-wi-25547https://curecurrent.com/trials/efficacy-of-kinesio-taping-versus-compression-therapy-on-breast-lymphedema-induced-by-radiotherapy-after-breast-conservi-25548https://curecurrent.com/trials/capivasertib-cdk4-6i-fulvestrant-for-advanced-metastatic-hr-her2-breast-cancer-capitello-292-25549https://curecurrent.com/trials/intratumoral-int230-6-followed-by-neoadjuvant-immuno-chemotherapy-in-patients-with-early-tnbc-invincible-4-sakk-25550https://curecurrent.com/trials/a-study-of-cyclophosphamide-methotrexate-fluorouracil-cmf-for-people-with-breast-cancer-25551https://curecurrent.com/trials/monitoring-her2-breast-cancer-neoadjuvant-treatment-with-advanced-pet-mri-25552https://curecurrent.com/trials/standard-neoadjuvant-chemotherapy-versus-genomic-driven-chemotherapy-in-patients-with-breast-cancer-25553https://curecurrent.com/trials/a-study-to-evaluate-atx-898-in-participants-with-advanced-solid-tumors-25554https://curecurrent.com/trials/inadvance-surveillance-prevention-and-interception-in-a-population-at-risk-for-cancer-25555https://curecurrent.com/trials/clinical-investigation-of-the-effects-of-semiconductor-embedded-therapeutic-garments-on-cancer-related-cognitive-impairm-25556https://curecurrent.com/trials/semaglutide-and-structured-lifestyle-support-to-improve-heart-and-blood-vessel-health-in-postmenopausal-obese-breast-can-25557https://curecurrent.com/trials/comparing-supplemental-topical-agents-for-the-treatment-of-acute-radiation-dermatitis-in-patients-with-breast-cancer-25558https://curecurrent.com/trials/a-3d-printed-external-breast-prosthesis-for-the-improvement-of-patient-reported-outcomes-among-breast-cancer-patients-th-25559https://curecurrent.com/trials/testing-proton-craniospinal-radiation-therapy-versus-the-usual-radiation-therapy-for-leptomeningeal-metastasis-radiate-l-25560https://curecurrent.com/trials/effectiveness-of-video-based-movement-analysis-guided-personalized-rehabilitation-in-patients-with-chemotherapy-induced-25561https://curecurrent.com/trials/hippocampal-avoidance-in-craniospinal-irradiation-for-the-treatment-of-leptomeningeal-metastases-from-breast-cancer-or-n-25562https://curecurrent.com/trials/mobile-health-patient-navigation-for-the-improvement-of-screening-and-the-early-detection-of-breast-cancer-in-women-acce-25563https://curecurrent.com/trials/evaluating-the-use-of-patient-navigation-to-promote-timely-diagnostic-evaluation-during-the-covid-19-pandemic-25564https://curecurrent.com/trials/trastuzumab-rezetecan-followed-by-pyrotinib-and-trastuzumab-combined-with-capecitabine-as-first-line-treatment-for-advan-25565https://curecurrent.com/trials/exercise-during-chemotherapy-in-older-women-with-stage-i-iii-breast-cancer-25566https://curecurrent.com/trials/a-navigation-program-to-improve-survivorship-support-service-participation-among-non-metastatic-breast-cancer-survivors-25567https://curecurrent.com/trials/a-real-world-study-of-treatment-patterns-tolerability-and-effectiveness-of-cdk4-6-inhibition-in-hr-her2-negative-metasta-25568https://curecurrent.com/trials/neoadjuvant-sbrt-followed-by-nab-paclitaxel-combined-with-toripalimab-in-hr-her2-breast-cancer-25569https://curecurrent.com/trials/tai-chi-for-reducing-aromatase-inhibitor-induced-arthralgia-25570https://curecurrent.com/trials/telehealth-weight-loss-program-for-breast-cancer-survivors-25571https://curecurrent.com/trials/paclitaxel-induced-polyneuropathy-in-breast-cancer-early-detection-risk-factors-quality-of-life-and-lifestyle-outcomes-25572https://curecurrent.com/trials/breast-cancer-plasma-adjuvant-intra-operative-treatment-breast-cancer-paint-25573https://curecurrent.com/trials/technetium-tc-99m-sulfur-colloid-injection-for-tracing-sentinel-nodes-in-breast-cancer-25574https://curecurrent.com/trials/megestrol-acetate-for-fatigue-management-in-t-dxd-treated-breast-cancer-25575https://curecurrent.com/trials/exercise-oncology-clinic-pilot-feasibility-trial-25576https://curecurrent.com/trials/evaluating-digital-micro-interventions-to-reduce-distress-and-increase-wellbeing-in-breast-cancer-survivors-25577https://curecurrent.com/trials/paclitaxel-therapeutic-drug-monitoring-in-cancer-patients-25578https://curecurrent.com/trials/systematic-intervention-to-improve-sexual-dysfunction-25579https://curecurrent.com/trials/pertuzumab-and-trastuzumab-as-neoadjuvant-treatment-in-patients-with-her2-positive-breast-cancer-25580https://curecurrent.com/trials/single-vs-multiple-injection-intertransverse-process-block-in-breast-cancer-surgery-25581https://curecurrent.com/trials/study-to-assess-gtaexs617-in-participants-with-advanced-solid-tumors-25582https://curecurrent.com/trials/nipple-areola-complex-nac-irradiation-after-nipple-sparing-mastectomy-and-reconstruction-25583https://curecurrent.com/trials/project-1-self-triage-by-2d-full-field-digital-mammography-or-synthetic-images-25584https://curecurrent.com/trials/weight-management-after-cancer-for-survivors-in-rural-communities-25585https://curecurrent.com/trials/op-1250-palazestrant-vs-standard-of-care-for-the-treatment-of-er-her2-advanced-breast-cancer-25586https://curecurrent.com/trials/a-study-of-gdc-9545-alone-or-in-combination-with-palbociclib-and-or-luteinizing-hormone-releasing-hormone-lhrh-agonist-i-25587https://curecurrent.com/trials/trust-ace-anticancer-treatment-cardiotoxicity-identification-by-echocardiography-25588https://curecurrent.com/trials/advance-a-pilot-trial-25589https://curecurrent.com/trials/omission-of-adjuvant-radiotherapy-in-young-low-risk-ductal-carcinoma-in-situ-following-breast-conserving-surgery-25590https://curecurrent.com/trials/administering-peripheral-blood-lymphocytes-transduced-with-a-cd70-binding-chimeric-antigen-receptor-to-people-with-cd70-25591https://curecurrent.com/trials/omission-of-adjuvant-radiotherapy-in-low-and-intermediate-risk-ductal-carcinoma-in-situ-after-breast-conserving-surgery-25592https://curecurrent.com/trials/supervised-exercise-during-neoadjuvant-chemotherapy-for-breast-cancer-25593https://curecurrent.com/trials/auricular-acupressure-for-perioperative-anxiety-and-pain-in-therapeutic-breast-surgery-rosa-25594https://curecurrent.com/trials/medical-imaging-and-focused-ultrasound-treatment-for-breast-tumors-using-harmonic-motion-imaging-hmi-25595https://curecurrent.com/trials/grace-trial-a-randomized-active-controlled-trial-for-vulvovaginal-atrophy-in-breast-cancer-patients-on-endocrine-therapy-25596https://curecurrent.com/trials/lifestyle-intervention-for-the-reduction-of-breast-cancer-risk-in-normal-weight-women-25597https://curecurrent.com/trials/lympha-procedure-for-the-prevention-of-lymphedema-after-axillary-lymphadenectomy-25598https://curecurrent.com/trials/the-power-trial-personalised-dose-optimisation-with-adjuvant-tamoxifen-therapy-in-breast-cancer-25599https://curecurrent.com/trials/acupuncture-pilot-study-for-cancer-related-cognitive-function-25600https://curecurrent.com/trials/optimizing-a-mhealth-physical-activity-intervention-with-mindful-awareness-lessons-in-breast-cancer-survivors-25601https://curecurrent.com/trials/evaluating-the-implementation-and-effectiveness-of-the-pink-and-pearl-campaign-on-lung-cancer-screening-at-christian-hos-25602https://curecurrent.com/trials/adaptive-therapy-with-capecitabine-for-treatment-of-metastatic-er-positive-her2-negative-breast-cancer-25603https://curecurrent.com/trials/ibcsg-trial-22-00-serum-substudy-25604https://curecurrent.com/trials/implementation-and-effectiveness-of-the-bjc-pink-and-pearl-project-on-lung-cancer-screening-25605https://curecurrent.com/trials/overcoming-racial-disparities-in-screening-mammography-25606https://curecurrent.com/trials/tt-702-in-patients-with-advanced-solid-tumours-25607https://curecurrent.com/trials/contrast-enhanced-mammography-for-the-evaluation-of-mammographic-microcalcifications-25608https://curecurrent.com/trials/an-open-label-randomized-phase-iii-study-of-trastuzumab-rezetecan-with-or-without-everolimus-in-first-to-third-line-lar-25609https://curecurrent.com/trials/long-term-outcomes-of-lidocaine-infusions-for-post-operative-pain-lolipop-trial-25610https://curecurrent.com/trials/copenhagen-master-observational-trial-25611https://curecurrent.com/trials/diep-mds-for-risk-stratification-of-flap-vascular-compromise-and-failure-in-breast-reconstruction-25612https://curecurrent.com/trials/fih-study-of-rgt-419b-alone-and-with-endocrine-therapy-in-hr-positive-her2-negative-advanced-metastatic-breast-cancer-25613https://curecurrent.com/trials/aromatherapy-combined-with-standard-antiemetic-therapy-vs-standard-therapy-alone-for-prevention-of-cinv-in-breast-cancer-25614https://curecurrent.com/trials/a-phase-1-multicenter-imaging-study-of-lnth-2403-in-participants-with-locally-advanced-or-metastatic-solid-tumors-25615https://curecurrent.com/trials/social-and-environmental-determinants-of-breast-cancer-survivorship-the-black-breast-cancer-survivor-s-intervention-bbcs-25616https://curecurrent.com/trials/double-blind-randomized-controlled-trial-comparing-suvorexant-20-mg-to-placebo-for-treatment-of-insomnia-in-cancer-survi-25617https://curecurrent.com/trials/sequencing-antibody-drug-conjugates-in-er-her2-low-ultra-low-mbc-25618https://curecurrent.com/trials/retrospective-and-prospective-evaluation-of-scapulohumeral-comfort-aesthetic-result-and-quality-of-life-25619https://curecurrent.com/trials/diagnostic-prediction-model-for-de-novo-metastatic-breast-cancer-25620https://curecurrent.com/trials/paclitaxel-and-trastuzumab-with-or-without-lapatinib-in-treating-patients-with-stage-ii-or-stage-iii-breast-cancer-that-25621https://curecurrent.com/trials/behavioral-pain-intervention-for-older-cancer-patients-25622https://curecurrent.com/trials/tnbc-gut-microbiota-during-neoadjuvant-treatment-25623https://curecurrent.com/trials/increasing-screening-for-cancer-using-ehr-nudges-replication-25624https://curecurrent.com/trials/serial-circulating-tumor-dna-ctdna-monitoring-during-adjuvant-capecitabine-in-early-triple-negative-breast-cancer-25625https://curecurrent.com/trials/updates-and-insights-on-her2-in-breast-cancer-in-sohag-governorate-25626https://curecurrent.com/trials/her2-car-t-cells-in-treating-patients-with-recurrent-brain-or-leptomeningeal-metastases-25627https://curecurrent.com/trials/68ga-sorb-pet-ct-imaging-in-patients-with-solid-tumors-25628https://curecurrent.com/trials/investigation-of-the-effectiveness-of-progressive-resistance-exercise-training-in-the-management-of-lymphedema-25629https://curecurrent.com/trials/establishment-and-clinical-transformation-of-adc-drug-efficacy-evaluation-system-for-breast-cancer-based-on-molecular-im-25630https://curecurrent.com/trials/a-study-of-t-dxd-in-participants-with-or-without-brain-metastasis-who-have-previously-treated-advanced-or-metastatic-her-25631https://curecurrent.com/trials/partial-breast-irradiation-without-sentinel-lymph-node-biopsy-in-low-risk-early-breast-cancer-25632https://curecurrent.com/trials/slow-jogging-for-breast-cancer-survivors-25633https://curecurrent.com/trials/mammography-early-detection-biomarkers-risk-assessment-and-imaging-technologies-merit-study-25634https://curecurrent.com/trials/trastuzumab-deruxtecan-t-dxd-alone-or-in-sequence-with-thp-versus-standard-treatment-ddac-thp-in-her2-positive-early-bre-25635https://curecurrent.com/trials/precision-regional-node-irradiation-for-sentinel-node-positive-breast-cancer-25636https://curecurrent.com/trials/comprehensive-lifestyle-change-to-prevent-breast-cancer-25637https://curecurrent.com/trials/a-study-to-assess-safety-tolerability-and-imaging-characteristics-of-68ga-ga-dpi-4452-and-to-assess-safety-tolerability-25638https://curecurrent.com/trials/gonadotropin-releasing-hormone-agonists-benefit-in-preserving-the-ovarian-function-in-premenopausal-breast-cancer-patien-25639https://curecurrent.com/trials/preventing-high-blood-sugar-in-people-being-treated-for-metastatic-breast-cancer-25640https://curecurrent.com/trials/contrast-enhanced-spectral-mammography-for-the-evaluation-of-pathologic-nipple-discharge-25641https://curecurrent.com/trials/a-trial-of-hrs-6209-205-to-evaluate-the-safety-tolerability-pharmacokinetics-and-efficacy-of-hrs-6209-in-combination-the-25642https://curecurrent.com/trials/a-phase-ii-study-of-ssgj-612-plus-a-her2-targeted-adc-in-hr-positive-her2-low-or-her2-ultralow-expression-metastatic-bre-25643https://curecurrent.com/trials/a-study-of-sim0270-combined-with-everolimus-vs-treatment-of-physician-s-choice-in-patients-with-er-her2-advanced-breast-25644https://curecurrent.com/trials/a-study-of-mgc026-in-participants-with-advanced-solid-tumors-25645https://curecurrent.com/trials/evaluating-omitting-of-internal-mammary-irradiation-among-early-stage-intermediate-risk-n1-breast-cancer-25646https://curecurrent.com/trials/metronomic-oral-paclitaxel-monotherapy-for-advanced-her2-negative-breast-cancer-a-two-stage-dose-finding-and-expansion-s-25647https://curecurrent.com/trials/a-comparative-study-of-delayed-endoscopic-dti-and-latissimus-dorsi-impalnt-reconstruction-post-mastectomy-25648https://curecurrent.com/trials/non-interventional-study-to-assess-the-effectiveness-and-safety-of-ribociclib-in-the-adjuvant-therapy-of-hormone-recepto-25649https://curecurrent.com/trials/effect-of-a-mushroom-extract-containing-topical-cosmetic-formulation-during-breast-radiotherapy-25650https://curecurrent.com/trials/trial-to-study-anti-hcmv-therapy-in-breast-cancer-patients-with-progressive-intracranial-metastases-and-cmv-infection-25651https://curecurrent.com/trials/a-blended-e-health-intervention-to-improve-fear-of-progression-in-women-with-gynecologic-or-breast-cancer-25652https://curecurrent.com/trials/supporting-health-including-endocrine-treatment-for-long-duration-25653https://curecurrent.com/trials/a-prospective-multicenter-study-of-the-tufest-ln-model-for-axillary-lymph-node-status-assessment-in-breast-cancer-25654https://curecurrent.com/trials/medical-imaging-to-re-evaluate-elacestrant-clinical-usage-25655https://curecurrent.com/trials/iit2023-09-chung-upfronttad-upfront-tad-snb-in-patients-with-breast-cancer-with-nodal-metastases-25656https://curecurrent.com/trials/safety-and-efficacy-of-omission-of-sentinel-node-biopsy-in-patients-with-estrogen-positive-breast-cancer-over-age-65-25657https://curecurrent.com/trials/smc-radiation-oncology-breast-cancer-cohort-study-25658https://curecurrent.com/trials/connecting-black-families-in-houston-texas-to-hereditary-cancer-genetic-counseling-genetic-testing-and-cascade-testing-b-25659https://curecurrent.com/trials/testing-the-combination-of-the-anticancer-drugs-zen003694-and-binimetinib-in-patients-with-advanced-metastatic-or-unrese-25660https://curecurrent.com/trials/5-strain-probiotic-formulation-in-hr-positive-breast-cancer-receiving-aromatase-inhibitor-to-prevent-bone-loss-25661https://curecurrent.com/trials/a-study-of-izalontamab-brengitecan-versus-chemotherapy-in-participants-with-previously-untreated-locally-advanced-recurr-25662https://curecurrent.com/trials/deep-optical-imaging-of-tissue-doit-25663https://curecurrent.com/trials/prospective-cohort-for-tumor-bed-boost-radiotherapy-in-her2-positive-breast-cancer-25664https://curecurrent.com/trials/orion-1-study-of-avzo-023-as-a-single-agent-and-in-combination-with-avzo-021-and-or-endocrine-therapy-in-advanced-solid-25665https://curecurrent.com/trials/an-adjuvant-endocrine-based-therapy-study-of-camizestrant-azd9833-in-er-her2-early-breast-cancer-cambria-2-25666https://curecurrent.com/trials/surveillance-mri-registry-for-patients-who-had-breast-cancer-with-dense-breast-tissue-25667https://curecurrent.com/trials/development-and-dissemination-of-exercise-prescription-and-intervention-for-cancer-populations-25668https://curecurrent.com/trials/axillary-radiotherapy-or-axillary-lymph-node-dissection-in-patients-with-clinically-node-positive-breast-cancer-undergoi-25669https://curecurrent.com/trials/lifestyle-intervention-to-enhance-efficacy-of-neoadjuvant-therapy-in-patients-with-triple-negative-breast-cancer-25670https://curecurrent.com/trials/determinants-of-resistance-to-endocrine-therapy-and-a-cyclin-dependent-kinases-4-and-6-cdk4-6-inhibitor-for-hr-mbc-25671https://curecurrent.com/trials/evaluation-and-risk-assessment-for-persistent-postsurgical-pain-after-breast-surgery-25672https://curecurrent.com/trials/marker-adjusted-therapy-comparing-adjuvant-elacestrant-with-standard-endocrine-treatment-in-genomically-and-or-clinicall-25673https://curecurrent.com/trials/a-study-of-lg00313112-in-participants-with-advanced-solid-malignancies-harboring-a-tp53-y220c-mutation-25674https://curecurrent.com/trials/evaluating-smoking-cessation-protocols-in-cancer-patients-nrt-mi-cbt-or-hypnotherapy-25675https://curecurrent.com/trials/evaluation-of-a-genetic-risk-score-for-lung-metastasis-and-prognosis-in-breast-cancer-25676https://curecurrent.com/trials/a-first-in-human-study-of-men2312-in-adults-with-advanced-breast-cancer-25677https://curecurrent.com/trials/effect-of-ckc-and-ws-exercises-on-postural-stability-in-unilateral-post-mastectomy-lymphedema-25678https://curecurrent.com/trials/a-phase-1-study-of-atv-1601-in-patients-with-advanced-cancer-that-have-akt1-e17k-mutations-25679https://curecurrent.com/trials/endocrine-response-in-women-with-invasive-lobular-breast-cancer-25680https://curecurrent.com/trials/retlirafusp-alfa-combined-with-chemotherapy-or-fuzuloparib-for-triple-negative-breast-cancer-25681https://curecurrent.com/trials/disco-a-patient-intervention-to-reduce-the-financial-burden-of-cancer-25682https://curecurrent.com/trials/dato-base-datopotamab-deruxtecan-for-breast-cancer-brain-metastases-25683https://curecurrent.com/trials/breast-cancer-psma-pet-25684https://curecurrent.com/trials/aurora-aiming-to-understand-the-molecular-aberrations-in-metastatic-breast-cancer-25685https://curecurrent.com/trials/the-sappho-study-sequential-therapy-with-curative-intent-in-de-novo-her2-metastatic-breast-cancer-25686https://curecurrent.com/trials/the-effect-of-artificial-intelligence-chatbot-and-expert-education-on-breast-cancer-awareness-among-female-municipal-emp-25687https://curecurrent.com/trials/the-effect-of-virtual-reality-glasses-and-breathing-exercise-on-anxiety-25688https://curecurrent.com/trials/docetaxel-and-cyclophosphamide-compared-to-anthracycline-based-chemotherapy-in-treating-women-with-her2-negative-breast-25689https://curecurrent.com/trials/shr-a1811-versus-investigator-s-chemotherapy-in-recurrent-metastatic-breast-cancer-clinical-trial-25690https://curecurrent.com/trials/phase-3-study-to-evaluate-the-efficacy-and-safety-of-her2-neu-peptide-glsi-100-gp2-gm-csf-in-her2-neu-positive-subjects-25691https://curecurrent.com/trials/a-first-in-human-dose-escalation-and-expansion-study-to-evaluate-the-safety-and-tolerability-of-azd8421-alone-or-in-comb-25692https://curecurrent.com/trials/repeat-breast-conserving-surgery-followed-by-daily-partial-breast-irradiation-in-ipsilateral-breast-25693https://curecurrent.com/trials/online-nutrition-education-to-decrease-the-side-effects-of-chemotherapy-in-patients-with-breast-cancer-25694https://curecurrent.com/trials/stop-her2-stopping-trastuzumab-in-her2-mbc-25695https://curecurrent.com/trials/generative-ai-patient-education-module-for-breast-oncology-25696https://curecurrent.com/trials/a-study-to-evaluate-arv-6723-alone-and-with-pembrolizumab-in-participants-with-advanced-solid-tumors-25697https://curecurrent.com/trials/breast-cancer-molecular-subtypes-and-skeletal-metastases-patterns-on-bone-scintigraphy-25698https://curecurrent.com/trials/mon-parcours-de-vie-localized-breast-cancer-announcement-support-information-on-the-disease-and-treatments-pilot-study-t-25699https://curecurrent.com/trials/the-breast-program-translational-cancer-resource-25700https://curecurrent.com/trials/pembrolizumab-vs-observation-in-people-with-triple-negative-breast-cancer-who-had-a-pathologic-complete-response-after-c-25701https://curecurrent.com/trials/planning-grant-for-tops-for-breast-cancer-survivors-25702https://curecurrent.com/trials/promoting-breast-cancer-screening-in-women-who-survived-childhood-cancer-25703https://curecurrent.com/trials/phase-ii-trial-of-pembrolizumab-chemotherapy-with-live-biotherapeutic-product-mo-03-in-patients-with-early-stage-triple-25704https://curecurrent.com/trials/impact-of-intermittent-fasting-on-biomarkers-of-inflammation-and-health-related-quality-of-life-a-feasibility-trial-for-25705https://curecurrent.com/trials/vitamin-d-and-physical-activity-on-bone-health-25706https://curecurrent.com/trials/study-on-female-patients-mammographic-texture-features-25707https://curecurrent.com/trials/clinical-study-to-assess-the-safety-and-performance-of-kenko-breast-ai-medical-device-as-an-aid-to-breast-cancer-diagnos-25708https://curecurrent.com/trials/trpc6-characterization-to-predict-and-prevent-chemotherapy-related-cardiomyopathy-and-heart-failure-with-breast-cancer-25709https://curecurrent.com/trials/neoadjuvant-therapy-comparing-sacituzumab-govitecan-pembrolizumab-vs-soc-chemotherapy-in-clinical-stage-ii-iii-triple-ne-25710https://curecurrent.com/trials/de-escalation-neoadjuvant-therapy-for-intermediate-risk-her2-positive-early-breast-25711https://curecurrent.com/trials/dose-response-of-aerobic-training-in-women-at-high-risk-for-development-of-breast-cancer-25712https://curecurrent.com/trials/therapeutic-education-and-nursing-support-program-for-supportive-care-in-patients-treated-with-hormone-therapy-for-non-m-25713https://curecurrent.com/trials/first-line-ribociclib-plus-endocrine-therapy-versus-chemotherapy-with-or-without-subsequent-endocrine-therapy-in-patient-25714https://curecurrent.com/trials/phase-iii-study-to-evaluate-the-safety-efficacy-and-impact-on-quality-of-life-of-capivasertib-alongside-standard-of-care-25715https://curecurrent.com/trials/her2-cns-surveillance-25716https://curecurrent.com/trials/short-term-pre-operative-durvalumab-medi-4736-in-early-small-triple-negative-breast-cancer-patients-pop-durva-25717https://curecurrent.com/trials/proofs-registry-premenopausal-women-with-breast-cancer-optimally-treated-with-ofs-25718https://curecurrent.com/trials/ivermectin-in-combination-with-balstilimab-or-pembrolizumab-in-patients-with-metastatic-triple-negative-breast-cancer-25719https://curecurrent.com/trials/clinical-significance-of-germline-brca-mutations-25720https://curecurrent.com/trials/cardiac-outcomes-with-near-complete-estrogen-deprivation-25721https://curecurrent.com/trials/idov-immune-for-advanced-solid-tumors-25722https://curecurrent.com/trials/the-effect-of-acupuncture-on-nerve-pain-caused-by-taxane-chemotherapy-treatment-25723https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-ifinatamab-deruxtecan-i-dxd-in-subjects-with-recurrent-or-metastatic-soli-25724https://curecurrent.com/trials/paclitaxel-oral-solution-in-triple-neagtive-breast-cancer-neoadjuvant-therapy-a-dose-finding-study-25725https://curecurrent.com/trials/a-real-world-study-observing-treatment-patterns-and-clinical-results-for-patients-in-china-with-hormone-receptor-positiv-25726https://curecurrent.com/trials/paclitaxel-oral-solution-in-her2-positive-breast-cancer-neoadjuvant-therapy-a-dose-finding-study-25727https://curecurrent.com/trials/low-dose-tamoxifen-with-or-without-omega-3-fatty-acids-for-breast-cancer-risk-reduction-25728https://curecurrent.com/trials/mind-body-interventions-for-the-improvement-of-quality-of-life-stress-and-sleep-quality-among-survivors-of-breast-prosta-25729https://curecurrent.com/trials/e-mindfulness-approaches-for-living-after-breast-cancer-25730https://curecurrent.com/trials/evaluating-interventions-for-breast-cancer-screening-in-ghana-25731https://curecurrent.com/trials/a-cancer-vaccine-stemvac-in-combination-with-chemotherapy-for-the-treatment-of-pd-l1-negative-metastatic-triple-negative-25732https://curecurrent.com/trials/a-study-of-novel-anti-cancer-agents-in-patients-with-metastatic-triple-negative-breast-cancer-25733https://curecurrent.com/trials/a-randomized-controlled-trial-rct-to-determine-the-efficacy-of-a-multidisciplinary-cbt-based-pain-management-program-for-25734https://curecurrent.com/trials/bupivacaine-vs-placebo-for-unilateral-mastectomy-surgical-site-post-operative-pain-control-25735https://curecurrent.com/trials/tart-cherry-and-omega-3-s-for-aromatase-inhibitor-musculoskeletal-symptoms-25736https://curecurrent.com/trials/neoadjuvant-angiogenesis-targeting-bispecific-chemoimmunotherapy-for-tnbc-25737https://curecurrent.com/trials/culmerciclib-plus-anlotinib-and-endocrine-therapy-for-hr-positive-her2-negative-metastatic-breast-cancer-with-brain-meta-25738https://curecurrent.com/trials/phase-ii-trial-of-ivonescimab-in-combination-with-carboplatin-docetaxel-in-patients-with-early-stage-triple-negative-bre-25739https://curecurrent.com/trials/affecting-factors-for-chronic-pain-after-mastectomy-25740https://curecurrent.com/trials/olanzapine-based-dexamethasone-sparing-regimen-for-breast-cancer-patients-with-metabolic-risk-factors-25741https://curecurrent.com/trials/pre-operative-therapy-in-breast-cancer-25742https://curecurrent.com/trials/study-of-ace-86225106-to-treat-patients-with-advanced-solid-tumors-25743https://curecurrent.com/trials/use-of-sentinel-lymph-node-biopsy-in-patients-with-early-stage-palpable-node-positive-hr-her2-breast-cancer-having-upfro-25744https://curecurrent.com/trials/methylation-profile-test-methylscape-in-body-fluids-for-multi-cancer-detection-and-monitoring-in-colombia-25745https://curecurrent.com/trials/clinical-trial-evaluating-the-biological-activity-of-a-new-drug-identified-as-prifetrastat-pf-07248144-combined-with-ful-25746https://curecurrent.com/trials/a-phase-1b-study-of-t-dxd-combinations-in-her2-low-advanced-or-metastatic-breast-cancer-25747https://curecurrent.com/trials/a-study-of-meaning-centered-therapy-for-mexican-adults-with-advanced-cancer-25748https://curecurrent.com/trials/testing-two-different-drugs-sacituzumab-govitecan-and-trastuzumab-deruxtecan-combinations-prescribed-in-an-alterning-pat-25749https://curecurrent.com/trials/effect-of-preoperative-rehabilitation-exercise-on-improving-postoperative-lymphedema-quality-of-life-and-care-needs-in-p-25750https://curecurrent.com/trials/histamine-and-bone-pain-association-in-participants-with-breast-cancer-metastatic-in-the-bone-25751https://curecurrent.com/trials/neoadj-therapy-comparing-sacituzumab-govitecan-sg-vs-sg-pembrolizumab-in-low-risk-triple-neg-ebc-adapt-tn-iii-25752https://curecurrent.com/trials/the-effect-of-myofascial-chain-release-techniques-on-shoulder-joint-range-of-motion-in-breast-cancer-survivors-25753https://curecurrent.com/trials/detecting-tumor-dna-in-the-blood-of-hr-her2-low-metastatic-breast-cancer-patients-to-find-candidates-for-t-dxd-therapy-25754https://curecurrent.com/trials/integrative-approaches-for-cancer-survivorship-iacs3-25755https://curecurrent.com/trials/a-study-of-vericiguat-in-people-with-breast-cancer-and-cancer-therapy-related-cardiac-dysfunction-25756https://curecurrent.com/trials/the-effect-of-dyadic-self-care-education-provided-to-breast-cancer-patient-caregiver-dyads-on-patient-and-caregiver-outc-25757https://curecurrent.com/trials/long-term-evaluation-of-quality-of-life-and-aesthetic-outcomes-after-autologous-breast-reconstruction-using-the-profunda-25758https://curecurrent.com/trials/tracking-triple-negative-breast-cancer-evolution-through-therapy-25759https://curecurrent.com/trials/implementing-polygenic-risk-scores-for-breast-cancer-prevention-a-feasibility-study-25760https://curecurrent.com/trials/saber-study-for-selected-early-stage-breast-cancer-25761https://curecurrent.com/trials/robotic-assisted-vs-endoscopic-assisted-sentinel-lymph-node-biopsy-in-breast-cancer-25762https://curecurrent.com/trials/instagram-and-podcast-intervention-for-breast-cancer-awareness-and-screening-25763https://curecurrent.com/trials/adaptive-symptom-self-management-immunotherapy-study-25764https://curecurrent.com/trials/antibody-based-pet-imaging-and-treatment-response-in-breast-cancer-treated-with-an-antibody-drug-conjugate-25765https://curecurrent.com/trials/testing-the-addition-of-an-anti-cancer-drug-bay-1895344-to-the-usual-chemotherapy-treatment-cisplatin-or-cisplatin-and-g-25766https://curecurrent.com/trials/optimising-adjuvant-chemotherapy-prescription-in-young-patients-with-hormone-dependent-breast-cancer-using-genomic-tests-25767https://curecurrent.com/trials/investigation-of-tumour-spectrum-of-germline-mutations-in-breast-and-ovarian-cancer-genes-25768https://curecurrent.com/trials/long-term-cohort-study-of-adding-ovarian-function-suppression-to-tamoxifen-in-young-women-25769https://curecurrent.com/trials/testing-the-addition-of-copanlisib-to-eribulin-in-metastatic-triple-negative-breast-cancer-25770https://curecurrent.com/trials/testing-the-addition-of-an-anti-cancer-drug-berzosertib-to-the-usual-treatment-radiation-therapy-for-chemotherapy-resist-25771https://curecurrent.com/trials/physical-activity-targeting-metabolic-syndrome-for-prevention-of-breast-cancer-in-sai-women-25772https://curecurrent.com/trials/ketoconazole-before-surgery-in-treating-patients-with-recurrent-glioma-or-breast-cancer-brain-metastases-25773https://curecurrent.com/trials/analgesic-efficacy-of-combined-pecs-ii-and-pip-block-versus-thoracic-paravertebral-block-post-mastectomy-25774https://curecurrent.com/trials/safety-study-of-adding-everolimus-to-adjuvant-hormone-therapy-in-women-with-high-risk-of-relapse-er-and-her2-primary-bre-25775https://curecurrent.com/trials/a-vaccine-mv-s-nap-for-the-treatment-of-patients-with-invasive-metastatic-breast-cancer-25776https://curecurrent.com/trials/testing-the-addition-of-an-anti-cancer-drug-astx727-cedazuridine-decitabine-to-chemotherapy-paclitaxel-and-immunotherapy-25777https://curecurrent.com/trials/a-study-of-a-side-effects-and-resource-navigation-program-for-people-with-cancer-25778https://curecurrent.com/trials/clinical-trial-evaluating-the-efficacy-and-implementation-of-an-early-adapted-physical-activity-to-prevent-and-manage-ar-25779https://curecurrent.com/trials/comparison-of-breast-cancer-screening-with-cesm-to-dbt-in-women-with-dense-breasts-25780https://curecurrent.com/trials/effects-of-negative-pressure-wound-bandaging-after-mastectomy-25781https://curecurrent.com/trials/match-up-making-telehealth-delivery-of-cancer-care-at-home-effective-and-safe-upscaled-a-pragmatic-cluster-randomized-tr-25782https://curecurrent.com/trials/testing-the-safety-and-efficacy-of-the-combination-of-two-anti-cancer-drugs-zen003694-and-abemaciclib-for-adult-and-pedi-25783https://curecurrent.com/trials/study-of-gvv858-as-a-single-agent-or-in-combination-with-endocrine-therapy-in-patients-with-hr-her2-breast-cancer-and-ot-25784https://curecurrent.com/trials/18f-fluoroazomycin-arabinoside-pet-ct-in-diagnosing-solid-tumors-in-patients-25785https://curecurrent.com/trials/safety-and-efficacy-of-t-dxd-vs-cdk4-6i-based-et-as-first-line-therapy-of-hr-positive-and-her2-low-ultralow-advanced-bre-25786https://curecurrent.com/trials/trastuzumab-deruxtecan-t-dxd-with-or-without-pertuzumab-versus-taxane-trastuzumab-and-pertuzumab-in-her2-positive-metast-25787https://curecurrent.com/trials/24gut540-meeting-of-breast-cancer-patients-and-pathologists-25788https://curecurrent.com/trials/a-trial-of-shr-a1811-compared-to-other-antitumor-therapies-as-neoadjuvant-treatments-in-early-stage-or-locally-advanced-25789https://curecurrent.com/trials/a-non-interventional-study-for-kisqali-ribociclib-in-combination-with-an-aromatase-inhibitor-for-adjuvant-treatment-in-p-25790https://curecurrent.com/trials/african-cancer-genome-gmd-25791https://curecurrent.com/trials/testing-trastuzumab-and-pertuzumab-in-patients-with-higher-than-normal-copies-of-the-her2-gene-found-in-their-tumors-mat-25792https://curecurrent.com/trials/study-of-ibreast-a-handheld-device-to-detect-breast-abnormalities-during-screening-visits-for-breast-cancer-25793https://curecurrent.com/trials/study-in-metastatic-breast-cancer-patients-receiving-eftilagimod-alpha-or-placebo-in-combination-with-paclitaxel-chemoth-25794https://curecurrent.com/trials/comparison-of-postoperative-analgesic-efficacy-of-two-different-blocks-in-modified-radical-mastectomy-surgery-25795https://curecurrent.com/trials/prevention-of-frailty-with-fisetin-and-exercise-in-breast-cancer-survivors-25796https://curecurrent.com/trials/intra-operative-detection-of-positive-margins-and-lymph-nodes-in-breast-surgery-25797https://curecurrent.com/trials/cyclophosphamide-paclitaxel-and-trastuzumab-in-treating-stage-i-ii-her2-neu-positive-breast-cancer-after-surgery-25798https://curecurrent.com/trials/tumor-derived-fgf19-25799https://curecurrent.com/trials/cognitive-training-for-cancer-related-cognitive-impairment-in-breast-cancer-survivors-25800https://curecurrent.com/trials/a-study-of-ribociclib-in-combination-with-hormonal-therapy-in-hr-her2-advanced-or-metastatic-breast-cancer-25801https://curecurrent.com/trials/analysis-of-breath-volatile-organic-compounds-using-mass-spectrometry-25802https://curecurrent.com/trials/a-study-of-bl-m07d1-bl-m07d1-pertuzumab-and-bl-m07d1-pertuzumab-docetaxel-in-patients-with-unresectable-locally-advanced-25803https://curecurrent.com/trials/anastrozole-palbociclib-trastuzumab-and-pertuzumab-in-hr-positive-her2-positive-metastatic-breast-25804https://curecurrent.com/trials/phase-i-study-of-177lu-lu-nns309-in-patients-with-pancreatic-lung-breast-and-colorectal-cancers-25805https://curecurrent.com/trials/effect-of-meal-timing-during-cancer-treatment-in-patients-in-alaska-a-randomized-clinical-trial-25806https://curecurrent.com/trials/culmerciclib-in-hr-her2-advanced-breast-cancer-25807https://curecurrent.com/trials/genetic-assessment-of-breast-cancer-risk-in-women-in-the-dora-programme-25808https://curecurrent.com/trials/rash-diarrhea-prophylaxis-with-capivasertib-25809https://curecurrent.com/trials/screening-tool-artificial-intelligence-based-for-predicting-the-genetic-risk-of-breast-cancer-25810https://curecurrent.com/trials/geriatric-oncology-assessment-and-coping-skills-training-for-older-women-on-aromatase-inhibitor-therapy-25811https://curecurrent.com/trials/pm8002-or-placebo-plus-nab-paclitaxel-as-first-line-treatment-in-inoperable-locally-advanced-metastatic-tnbc-25812https://curecurrent.com/trials/ultrahypofractionated-versus-normofractionated-sequential-boost-after-whole-breast-radiation-therapy-in-patients-treated-25813https://curecurrent.com/trials/social-media-based-education-on-cancer-screening-awareness-in-women-a-randomized-controlled-trial-25814https://curecurrent.com/trials/exercise-intervention-for-breast-cancer-patients-with-sarcopenia-25815https://curecurrent.com/trials/a-study-to-allow-continued-dosing-and-or-follow-up-of-patients-who-have-had-previous-exposure-to-poziotinib-25816https://curecurrent.com/trials/study-of-autologous-car-t-cells-targeting-b7-h3-in-tnbc-ic9-car-b7-h3-t-cells-25817https://curecurrent.com/trials/the-effect-of-a-virtual-reality-based-mindfulness-intervention-on-anxiety-comfort-sleep-and-fatigue-in-breast-cancer-pat-25818https://curecurrent.com/trials/a-phase-1-of-ctx-8371-in-patients-with-advanced-malignancies-25819https://curecurrent.com/trials/futibatinib-in-patients-previously-enrolled-in-an-antecedent-futibatinib-as-monotherapy-or-combination-therapy-25820https://curecurrent.com/trials/gene-therapy-for-her-positive-cancer-sentry-her2-25821https://curecurrent.com/trials/adherence-intervention-in-patients-with-metastatic-breast-cancer-25822https://curecurrent.com/trials/cemiplimab-in-high-risk-or-locally-advanced-luminal-and-triple-negative-breast-cancer-25823https://curecurrent.com/trials/endocrine-treatment-alone-for-elderly-patients-with-estrogen-receptor-positive-operable-breast-cancer-and-low-recurrence-25824https://curecurrent.com/trials/comparison-of-ce-dbt-and-mri-in-patients-with-known-breast-lesions-25825https://curecurrent.com/trials/molecular-neuroimaging-to-assess-the-link-between-neuroinflammation-and-cognitive-impairment-in-breast-cancer-25826https://curecurrent.com/trials/neoadjuvant-pembrolizumab-and-carboplatin-plus-paclitaxel-for-stage-i-triple-negative-breast-cancer-25827https://curecurrent.com/trials/neu-direction-testing-the-efficacy-of-adding-her-inhibition-to-standard-of-care-in-metastatic-mlh1-low-endocrine-resista-25828https://curecurrent.com/trials/exploring-breast-referral-behaviours-in-primary-care-25829https://curecurrent.com/trials/clinical-feasibility-study-of-upright-low-dose-high-resolution-3d-breast-ct-ubct-25830https://curecurrent.com/trials/mepitel-film-breast-25831https://curecurrent.com/trials/safety-and-tolerability-of-iph4502-in-patients-with-advanced-solid-tumors-25832https://curecurrent.com/trials/a-study-to-assess-the-efficacy-and-safety-of-fore8394-in-participants-with-cancer-harboring-braf-alterations-25833https://curecurrent.com/trials/finding-the-best-tamoxifen-dose-for-breast-cancer-risk-reduction-in-premenopausal-women-renaissance-trial-25834https://curecurrent.com/trials/durvalumab-with-olaparib-and-fulvestrant-in-advanced-er-her2-breast-cancer-patients-25835https://curecurrent.com/trials/smp-656-for-her2-positive-advanced-breast-cancer-25836https://curecurrent.com/trials/trial-of-anastrozole-and-palbociclib-in-metastatic-her2-negative-breast-cancer-25837https://curecurrent.com/trials/tomosynthesis-as-primary-test-for-breast-cancer-screening-25838https://curecurrent.com/trials/gemcitabine-trastuzumab-and-pertuzumab-in-the-treatment-of-metastatic-her2-positive-breast-cancer-after-prior-trastuzuma-25839https://curecurrent.com/trials/evaluating-the-impact-of-digital-behavioral-interventions-to-address-insomnia-and-depression-in-breast-cancer-survivors-25840https://curecurrent.com/trials/gq1001-combined-with-pyrotinib-for-treatment-with-her2-positive-metastatic-breast-cancer-25841https://curecurrent.com/trials/effects-of-a-web-based-alopecia-education-program-in-women-with-breast-cancer-25842https://curecurrent.com/trials/impact-of-pilates-exercises-on-bone-mineral-density-in-breast-cancer-survivors-receiving-hormonal-therapy-25843https://curecurrent.com/trials/novel-ga68-psma-pet-ct-tracer-to-differentiate-between-radiation-necrosis-and-tumor-progression-in-brain-metastases-25844https://curecurrent.com/trials/sac-tmt-for-active-tnbc-brain-metastases-25845https://curecurrent.com/trials/cirtuvivint-olaparib-in-breast-cancer-susceptibility-gene-homologous-recombination-deficiency-platinum-resistant-ovarian-25846https://curecurrent.com/trials/ascending-doses-of-ceralasertib-in-combination-with-chemotherapy-and-or-novel-anti-cancer-agents-25847https://curecurrent.com/trials/outcomes-and-cosmesis-with-whole-breast-irradiation-and-boost-25848https://curecurrent.com/trials/evaluation-of-the-pharmacokinetics-safety-and-tolerability-of-im-letrozole-lebe-in-healthy-post-menopausal-women-25849https://curecurrent.com/trials/atezolizumab-combined-with-bdb001-and-immunogenic-radiotherapy-in-patients-with-advanced-solid-tumors-25850https://curecurrent.com/trials/study-of-ruxolitinib-incb018424-with-preoperative-chemotherapy-for-triple-negative-inflammatory-breast-cancer-25851https://curecurrent.com/trials/hyaluronic-acid-for-prevention-of-post-intubation-sore-throat-and-hoarseness-25852https://curecurrent.com/trials/pembrolizumab-and-chemotherapy-treatment-or-no-treatment-guided-by-the-level-of-tils-in-resected-early-stage-tnbc-25853https://curecurrent.com/trials/de-escalation-of-rni-in-breast-cancer-patients-with-pn0-after-neoadjuvant-therapy-25854https://curecurrent.com/trials/radiation-after-no-axillary-nodal-sampling-25855https://curecurrent.com/trials/phase-3-trial-of-srg-514-administered-intraoperatively-to-patients-undergoing-breast-conserving-surgery-25856https://curecurrent.com/trials/a-study-of-tucatinib-vs-placebo-in-combination-with-ado-trastuzumab-emtansine-t-dm1-for-patients-with-advanced-or-metast-25857https://curecurrent.com/trials/gemcitabine-and-ex-vivo-expanded-allogenic-universal-donor-tgf-i-natural-killer-nk-cells-with-or-without-naxitamab-danye-25858https://curecurrent.com/trials/nuc-3373-in-combination-with-other-agents-in-patients-with-advanced-solid-tumours-25859https://curecurrent.com/trials/early-detection-of-triple-negative-breast-cancer-relapse-cupcake-25860https://curecurrent.com/trials/a-study-comparing-bl-b01d1-with-chemotherapy-of-physician-s-choice-in-patients-with-unresectable-locally-advanced-recurr-25861https://curecurrent.com/trials/gen1047-for-solid-tumors-first-in-human-fih-trial-25862https://curecurrent.com/trials/physical-exercise-on-metabolic-health-gut-microbiota-physical-fitness-and-quality-of-life-in-obese-breast-cancer-survivo-25863https://curecurrent.com/trials/the-effect-of-channa-striata-and-curcuma-supplementation-on-nutritional-status-interleukin-6-levels-and-quality-of-life-25864https://curecurrent.com/trials/personalised-behavioural-intervention-in-cancer-screening-programmes-25865https://curecurrent.com/trials/evaluation-of-68ga-ga-nota-anti-her2-sdab-pet-ct-for-predicting-pathological-complete-response-after-neoadjuvant-chemoth-25866https://curecurrent.com/trials/a-dose-finding-study-to-treat-bone-tumor-s-25867https://curecurrent.com/trials/a-vaccine-stemvac-for-improving-survival-in-patients-with-triple-negative-breast-cancer-and-moderate-or-extensive-residu-25868https://curecurrent.com/trials/olap-olaparib-regulatory-post-marketing-surveillance-25869https://curecurrent.com/trials/web-based-lifestyle-program-mhealth-and-ema-intervention-to-improve-weight-loss-in-rural-stage-i-iii-postmenopausal-brea-25870https://curecurrent.com/trials/a-study-of-bl-b01d1-pd-1-monoclonal-antibody-in-patients-with-unresectable-locally-advanced-or-recurrent-metastatic-trip-25871https://curecurrent.com/trials/studying-the-workflow-of-the-american-college-of-surgeons-geriatric-surgery-program-to-improve-clinical-outcomes-in-olde-25872https://curecurrent.com/trials/stemvac-in-patients-with-early-stage-triple-negative-breast-cancer-25873https://curecurrent.com/trials/the-florida-ascent-study-25874https://curecurrent.com/trials/iort-breast-at-medical-center-navicent-health-25875https://curecurrent.com/trials/study-of-orally-administered-moma-313-in-participants-with-advanced-or-metastatic-solid-tumors-25876https://curecurrent.com/trials/evaluation-of-an-online-intervention-to-educate-women-at-high-risk-of-breast-cancer-on-how-to-help-reduce-their-risk-25877https://curecurrent.com/trials/personalizing-the-use-of-pembrolizumab-for-patients-who-have-a-strong-response-in-early-triple-negative-breast-cancer-25878https://curecurrent.com/trials/exergames-acceptance-and-commitment-therapy-e-act-for-breast-cancer-depression-and-anxiety-a-randomized-controlled-trial-25879https://curecurrent.com/trials/a-study-comparing-bl-b01d1-with-chemotherapy-of-physician-s-choice-in-patients-with-unresectable-locally-advanced-recurr-25880https://curecurrent.com/trials/a-study-comparing-bl-m07d1-with-t-dm1-in-patients-with-unresectable-locally-advanced-or-metastatic-her2-positive-breast-25881https://curecurrent.com/trials/t-dxd-based-therapy-followed-by-endocrine-therapy-plus-dual-her2-blockade-in-first-line-her2-hr-metastatic-breast-cancer-25882https://curecurrent.com/trials/validation-of-capillary-microsampling-for-therapeutic-drug-monitoring-of-cdk4-6-inhibitors-in-breast-cancer-patients-tdh-25883https://curecurrent.com/trials/a-study-comparing-bl-b01d1-with-chemotherapy-of-physician-s-choice-in-patients-with-unresectable-locally-advanced-or-met-25884https://curecurrent.com/trials/a-study-of-pf-08046054-sgn-pdl1v-in-advanced-solid-tumors-25885https://curecurrent.com/trials/study-of-pembrolizumab-mk-3475-plus-chemotherapy-versus-placebo-plus-chemotherapy-for-hr-her2-locally-recurrent-inoperab-25886https://curecurrent.com/trials/a-phase-ii-study-of-ak146d1-combined-with-ak112-in-advanced-breast-cancer-25887https://curecurrent.com/trials/peri-operative-immune-checkpoint-inhibition-and-cryoablation-in-women-with-triple-negative-breast-cancer-25888https://curecurrent.com/trials/study-of-ly3410738-administered-to-patients-with-advanced-solid-tumors-with-idh1-or-idh2-mutations-25889https://curecurrent.com/trials/study-of-rgt-490-in-patients-with-pik3ca-mutated-advanced-solid-tumors-25890https://curecurrent.com/trials/tirzepatide-s-role-in-postmenopausal-hr-breast-cancer-survivors-25891https://curecurrent.com/trials/an-investigational-surgical-procedure-vascularized-lymph-node-transfer-in-reducing-the-risk-of-lymphedema-in-patients-wi-25892https://curecurrent.com/trials/a-study-of-imlunestrant-investigator-s-choice-of-endocrine-therapy-and-imlunestrant-plus-abemaciclib-in-participants-wit-25893https://curecurrent.com/trials/a-study-of-disitamab-vedotin-with-other-anticancer-drugs-in-solid-tumors-25894https://curecurrent.com/trials/personalized-neo-antigen-peptide-vaccine-for-the-treatment-of-stage-iiic-iv-melanoma-hormone-receptor-positive-her2-nega-25895https://curecurrent.com/trials/my-personalized-breast-screening-25896https://curecurrent.com/trials/value-of-ultrasound-guided-microwave-ablation-for-breast-fibroadenoma-25897https://curecurrent.com/trials/asciminib-in-her2-breast-cancer-brain-metastases-25898https://curecurrent.com/trials/endobreast-study-assessment-of-feasibility-functional-outcomes-and-sensitivity-of-the-areola-nipple-complex-in-endoscopi-25899https://curecurrent.com/trials/neoagora-exploring-clinical-utility-of-serial-liquid-biopsy-ctdna-in-patients-with-early-stage-breast-cancer-25900https://curecurrent.com/trials/a-study-to-learn-about-the-study-medicine-called-pf-08032562-in-people-with-advanced-or-metastatic-solid-tumors-25901https://curecurrent.com/trials/safety-and-performance-of-regenera-breast-implant-in-women-affected-by-malignant-breast-lesion-treated-by-lumpectomy-25902https://curecurrent.com/trials/endocrine-therapy-with-abemaciclib-or-chemotherapy-as-initial-metastatic-treatment-in-er-her2-breast-cancer-25903https://curecurrent.com/trials/malignant-pleural-disease-treated-with-autologous-t-cells-genetically-engineered-to-target-the-cancer-cell-surface-antig-25904https://curecurrent.com/trials/fulvestaciclib-combined-with-anti-her2-and-endocrine-therapy-for-hr-her2-advanced-breast-cancer-25905https://curecurrent.com/trials/comparing-5-and-15-fractions-for-whole-breast-irradiation-after-breast-conserving-surgery-25906https://curecurrent.com/trials/palbociclib-and-pembrolizumab-in-central-nervous-system-metastases-25907https://curecurrent.com/trials/real-world-data-in-patients-with-breast-cancer-treated-with-abemaciclib-25908https://curecurrent.com/trials/study-of-elacestrant-in-combination-with-onapristone-in-patients-with-advanced-or-metastatic-breast-cancer-25909https://curecurrent.com/trials/mri-characterization-of-mammographically-detected-dcis-25910https://curecurrent.com/trials/remotely-supervised-exercise-during-chemotherapy-in-women-with-breast-cancer-25911https://curecurrent.com/trials/comparing-continuation-or-de-escalation-of-bone-modifying-agents-bma-in-patients-treated-for-over-2-years-for-bone-metas-25912https://curecurrent.com/trials/decreasing-treatment-for-metastatic-her2-positive-breast-cancer-with-undectable-cancer-levels-in-blood-tests-25913https://curecurrent.com/trials/fes-imaging-to-optimize-tamoxifen-for-metastatic-breast-cancer-25914https://curecurrent.com/trials/auricular-point-stimulation-plus-dexamethasone-versus-standard-antiemetic-regimen-for-nausea-and-vomiting-caused-by-doce-25915https://curecurrent.com/trials/dendritic-cell-vaccines-against-her2-her3-and-pembrolizumab-for-the-treatment-of-brain-metastasis-from-triple-negative-b-25916https://curecurrent.com/trials/pilot-study-of-cabazitaxel-and-paclitaxel-in-her2-negative-breast-cancer-25917https://curecurrent.com/trials/sentinel-lymph-node-biopsy-after-neoadjuvant-chemotherapy-for-locally-advanced-breast-cancer-25918https://curecurrent.com/trials/auricular-point-stimulation-plus-dexamethasone-versus-standard-antiemetic-regimen-for-nausea-and-vomiting-caused-by-tras-25919https://curecurrent.com/trials/mri-driven-precision-typing-and-response-prediction-in-luminal-breast-cancer-25920https://curecurrent.com/trials/deescalation-of-endocrine-therapy-duration-in-women-with-hr-her2-breast-cancer-at-very-low-risk-25921https://curecurrent.com/trials/pharmacokinetic-model-of-abemaciclib-correlation-with-severe-diarrhea-as-the-primary-toxicity-endpoint-in-patients-with-25922https://curecurrent.com/trials/efficacy-and-safety-of-intrathecal-administration-of-thiotepa-in-combination-with-methotrexate-in-breast-cancer-with-lep-25923https://curecurrent.com/trials/wearable-ultrasound-patch-for-breast-imaging-25924https://curecurrent.com/trials/endocrine-therapy-induced-alopecia-in-postmenopausal-and-premenopausal-female-breast-cancer-patients-25925https://curecurrent.com/trials/first-line-nab-paclitaxel-plus-cisplatin-plus-camrelizumab-in-mtnbc-patients-25926https://curecurrent.com/trials/fluzoparib-combined-with-camrelizumab-for-neoadjuvant-treatment-of-embryogenic-brca-mutation-her2-negative-breast-cancer-25927https://curecurrent.com/trials/breast-lump-clipping-methods-comparison-25928https://curecurrent.com/trials/study-of-incb123667-in-subjects-with-advanced-solid-tumors-25929https://curecurrent.com/trials/rising-ctdna-to-tailor-endocrine-therapy-switch-in-patients-with-er-her2-metastatic-breast-cancer-25930https://curecurrent.com/trials/safety-and-efficacy-analysis-of-an-antibody-associated-with-a-chemotherapy-for-patients-with-a-triple-negative-metastati-25931https://curecurrent.com/trials/survival-outcomes-of-residual-disease-in-triple-negative-breast-cancer-25932https://curecurrent.com/trials/impact-of-metabolic-health-patterns-and-breast-cancer-over-time-in-women-25933https://curecurrent.com/trials/symptom-management-and-survivorship-plus-coaching-for-advanced-cancer-survivors-and-their-caregivers-25934https://curecurrent.com/trials/imaging-performance-assessment-of-89zi-girentuximab-89zr-tlx250-pet-in-metastatic-triple-negative-breast-cancer-25935https://curecurrent.com/trials/adjuvant-systemic-treatment-for-er-positive-her2-negative-breast-carcinoma-in-women-over-70-according-to-genomic-grade-g-25936https://curecurrent.com/trials/what-is-optimal-post-operative-prophylactic-therapy-in-irradiated-breasts-undergoing-repeat-surgery-25937https://curecurrent.com/trials/the-aviator-study-trastuzumab-and-vinorelbine-with-avelumab-or-avelumab-utomilumab-in-advanced-her2-breast-cancer-25938https://curecurrent.com/trials/proton-radiation-therapy-for-invasive-breast-cancer-following-mastectomy-25939https://curecurrent.com/trials/dance-study-for-post-surgical-pain-in-breast-cancer-survivors-25940https://curecurrent.com/trials/sacituzumab-govitecan-in-tnbc-25941https://curecurrent.com/trials/adjuvant-therapy-with-an-alpha-lactalbumin-vaccine-in-triple-negative-breast-cancer-25942https://curecurrent.com/trials/sulindac-and-breast-density-in-women-at-risk-of-developing-breast-cancer-25943https://curecurrent.com/trials/letrozole-with-and-without-simvastatin-for-the-treatment-of-stage-i-iii-hormone-receptor-positive-her2-negative-breast-c-25944https://curecurrent.com/trials/virtual-mindful-after-cancer-mac-intervention-to-promote-sexual-health-for-breast-and-gynecologic-cancer-survivors-25945https://curecurrent.com/trials/study-comparing-the-standard-administration-of-io-versus-the-same-io-administered-each-3-months-in-patients-in-response-25946https://curecurrent.com/trials/telehealth-resistance-exercise-intervention-to-preserve-dose-intensity-and-vitality-in-elder-breast-cancer-patients-25947https://curecurrent.com/trials/her2-positive-breast-cancer-registry-25948https://curecurrent.com/trials/trial-of-single-protein-encapsulated-doxorubicin-spedox-6-in-advanced-malignancies-25949https://curecurrent.com/trials/evaluating-dose-timing-morning-vs-evening-of-endocrine-based-therapies-in-metastatic-breast-and-prostate-cancers-25950https://curecurrent.com/trials/fisetin-to-improve-physical-function-in-stage-i-iii-breast-cancer-survivors-25951https://curecurrent.com/trials/partial-breast-re-irradiation-using-ultra-hypofractionation-preserve-25952https://curecurrent.com/trials/a-study-on-combined-low-pass-whole-genome-and-methylome-testing-of-bloody-nipple-discharge-specimens-for-benign-malignan-25953https://curecurrent.com/trials/overdiagnosis-and-breast-cancer-screening-decisions-25954https://curecurrent.com/trials/a-real-world-study-of-clinical-adoption-treatment-patterns-and-tolerability-of-adjuvant-ribociclib-in-hr-her2-early-brea-25955https://curecurrent.com/trials/digital-phenotyping-in-women-over-70-years-of-age-treated-for-breast-cancer-with-any-type-of-treatment-25956https://curecurrent.com/trials/lifestyle-exercise-and-nutrition-study-early-after-diagnosis-25957https://curecurrent.com/trials/a-study-of-e7090-as-monotherapy-and-in-combination-with-other-anticancer-agents-in-participants-with-estrogen-receptor-p-25958https://curecurrent.com/trials/a-phase-2-study-to-evaluate-the-efficacy-safety-and-pharmacokinetics-of-yl202-in-patients-with-bc-25959https://curecurrent.com/trials/tolerability-of-dalpiciclib-vs-abemaciclib-ribociclib-in-early-hr-her2-breast-cancer-25960https://curecurrent.com/trials/single-dose-preoperative-partial-breast-irradiation-in-low-risk-breast-cancer-patients-25961https://curecurrent.com/trials/nurse-delivered-adapted-mbsr-during-breast-cancer-radiotherapy-25962https://curecurrent.com/trials/breast-cancer-risk-assessment-in-night-shift-workers-implementation-of-a-personalized-consultation-25963https://curecurrent.com/trials/evaluating-an-endocrine-therapy-dose-frequency-escalation-strategy-and-its-effects-on-tolerability-and-compliance-25964https://curecurrent.com/trials/nectin-4-pet-to-predict-response-to-nectin-4-targeted-therapy-in-advanced-breast-cancer-25965https://curecurrent.com/trials/a-phase-i-single-arm-open-label-dose-escalation-study-to-evaluate-the-safety-and-tolerability-of-orialpha-bd-c-in-health-25966https://curecurrent.com/trials/phase-i-study-of-tumor-treating-fields-ttf-in-combination-with-cabozantinib-or-with-pembrolizumab-and-nab-paclitaxel-in-25967https://curecurrent.com/trials/evaluation-of-data-obtained-from-three-common-imaging-techniques-positron-emission-tomography-pet-ct-breast-ultrasound-a-25968https://curecurrent.com/trials/entinostat-plus-pyrotinib-and-endocrine-therapy-in-advanced-triple-positive-breast-cancer-after-trastuzumab-failure-25969https://curecurrent.com/trials/a-trial-of-hrs-6209-in-combination-with-fulvestrant-letrozole-hrs-8080-or-hrs-1358-in-breast-cancer-patients-25970https://curecurrent.com/trials/genetic-testing-to-improve-management-of-patients-undergoing-breast-biopsy-25971https://curecurrent.com/trials/the-c-merit-screening-cohort-contrast-enhanced-mammography-for-breast-cancer-screening-and-risk-assessment-in-women-with-25972https://curecurrent.com/trials/evaluating-the-effectiveness-of-typology-based-coaching-on-patients-therapy-management-25973https://curecurrent.com/trials/postoperative-re-irradiation-with-and-without-hyperthermia-or-surgery-only-toxicity-quality-of-life-and-survival-in-pati-25974https://curecurrent.com/trials/ribociclib-and-endocrine-treatment-of-physician-s-choice-for-locoregional-recurrent-resected-hormone-receptor-positive-h-25975https://curecurrent.com/trials/t-cell-therapy-for-advanced-breast-cancer-25976https://curecurrent.com/trials/gut-microbiota-and-diarrhea-in-breast-cancer-patients-receiving-pyrotinib-25977https://curecurrent.com/trials/chemotherapy-induced-cognitive-and-brain-changes-in-older-adults-with-breast-cancer-25978https://curecurrent.com/trials/phase-1-1b-2-study-of-oral-pmd-026-in-patients-with-metastatic-breast-cancer-25979https://curecurrent.com/trials/implementation-of-online-adaptive-radiotherapy-for-breast-cancer-patients-on-ethos-breast-art-25980https://curecurrent.com/trials/phase-1b-study-of-ezh1-2-inhibitor-valemetostat-in-combination-with-trastuzumab-deruxtecan-in-subjects-with-her2-low-ult-25981https://curecurrent.com/trials/preoperative-partial-breast-reirradiation-and-repeat-breast-conserving-surgery-in-patients-with-recurrent-breast-cancer-25982https://curecurrent.com/trials/granzyme-b-pet-predicting-immunotherapy-efficacy-in-tnbc-25983https://curecurrent.com/trials/mhealth-to-improve-medication-adherence-among-latina-breast-cancer-patients-experiencing-non-medical-drivers-of-health-25984https://curecurrent.com/trials/the-tasty-steering-study-25985https://curecurrent.com/trials/training-on-self-breast-examination-using-visual-breast-examination-materials-for-i-lliterate-women-25986https://curecurrent.com/trials/pembrolizumab-in-treating-patients-with-stage-iv-metastatic-or-recurrent-inflammatory-breast-cancer-or-triple-negative-b-25987https://curecurrent.com/trials/study-of-ribociclib-administered-concurrently-with-postoperative-radiation-therapy-in-patients-with-high-risk-hr-her2-br-25988https://curecurrent.com/trials/cdk4-6-inhibitors-in-metastatic-hr-positive-breast-cancer-25989https://curecurrent.com/trials/a-study-to-learn-about-the-study-medicine-pf-07220060-together-with-letrozole-compared-to-letrozole-alone-in-women-post-25990https://curecurrent.com/trials/hypofractionated-vs-conventional-regional-nodal-radiation-therapy-for-patients-with-invasive-breast-cancer-25991https://curecurrent.com/trials/skb264-plus-inetetamab-in-her2-positive-metastatic-breast-cancer-patients-progressing-after-t-dxd-treatment-25992https://curecurrent.com/trials/surgery-in-preventing-ovarian-cancer-in-patients-with-genetic-mutations-25993https://curecurrent.com/trials/a-study-to-learn-about-study-medicine-alta2618-in-adults-with-akt1-e17k-mutant-solid-tumors-25994https://curecurrent.com/trials/molecular-testing-and-imaging-in-improving-response-in-patients-with-stage-i-iii-triple-negative-breast-cancer-receiving-25995https://curecurrent.com/trials/fapi-pet-imaging-an-exploratory-study-25996https://curecurrent.com/trials/palbociclib-combine-with-anti-her2-therapy-in-triple-positive-abc-25997https://curecurrent.com/trials/pre-treatment-dce-mri-ai-models-predict-neoadjuvant-chemotherapy-response-in-hr-her2-breast-cancer-25998https://curecurrent.com/trials/a-phase-i-ii-study-of-medi4736-in-combination-with-olaparib-in-patients-with-advanced-solid-tumors-25999https://curecurrent.com/trials/a-study-comparing-cancer-imaging-approaches-in-people-with-lobular-breast-cancer-26000